{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "10",
                "@timestamp": "2023-07-10T23:41:27.000027-04:00",
                "@year": "2023",
                "@month": "07"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2021",
                "@month": "12"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": [
                {"xocs:funding-agency-matched-string": "ACEA Pharma"},
                {"xocs:funding-agency-matched-string": "Alpha Biopharma Co. Ltd."},
                {"xocs:funding-agency-matched-string": "Amoy Diagnostics Co. Ltd."},
                {"xocs:funding-agency-matched-string": "Aurora Tele-Oncology Ltd."},
                {"xocs:funding-agency-matched-string": "Biodesix"},
                {"xocs:funding-agency-matched-string": "Hengrui Therapeutics Inc."},
                {"xocs:funding-agency-matched-string": "Hutchison Chi-Med"},
                {"xocs:funding-agency-matched-string": "Ignyta Inc."},
                {"xocs:funding-agency-matched-string": "Liangyihui Network Technology Co. Ltd."},
                {"xocs:funding-agency-matched-string": "Lunit USA Inc."},
                {"xocs:funding-agency-matched-string": "Menarini"},
                {"xocs:funding-agency-matched-string": "Phosplatin Therapeutics"},
                {"xocs:funding-agency-matched-string": "Roche Ltd."},
                {"xocs:funding-agency-matched-string": "Roche Ltd., Merck, Sharp & Dohme"},
                {"xocs:funding-agency-matched-string": "SFJ Pharmaceuticals"},
                {"xocs:funding-agency-matched-string": "SFJ Pharmaceuticals Ltd."},
                {"xocs:funding-agency-matched-string": "Sanomics Ltd."},
                {"xocs:funding-agency-matched-string": "Seattle Genetics, Foundation Medicine, and Takeda"},
                {"xocs:funding-agency-matched-string": "Shanghai BeBirds Translation & Consulting Co. Ltd."},
                {
                    "xocs:funding-agency-matched-string": "Boehringer Ingelheim",
                    "xocs:funding-agency-acronym": "BI",
                    "xocs:funding-agency": "Boehringer Ingelheim",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100001003",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Amgen",
                    "xocs:funding-agency": "Amgen",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100002429",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Bristol-Myers Squibb",
                    "xocs:funding-agency-acronym": "BMS",
                    "xocs:funding-agency": "Bristol-Myers Squibb",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100002491",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Eli Lilly",
                    "xocs:funding-agency": "Eli Lilly and Company",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004312",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Pfizer",
                    "xocs:funding-agency": "Pfizer",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004319",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "AstraZeneca",
                    "xocs:funding-agency": "AstraZeneca",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004325",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2635167/"
                },
                {
                    "xocs:funding-agency-matched-string": "Genentech",
                    "xocs:funding-agency": "Genentech",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004328",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "GlaxoSmithKline",
                    "xocs:funding-agency-acronym": "GSK",
                    "xocs:funding-agency": "GlaxoSmithKline",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004330",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2635167/"
                },
                {
                    "xocs:funding-agency-matched-string": "Merck",
                    "xocs:funding-agency": "Merck",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004334",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Novartis",
                    "xocs:funding-agency": "Novartis",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004336",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2658434/"
                },
                {
                    "xocs:funding-agency-matched-string": "Roche",
                    "xocs:funding-agency": "Roche",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004337",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2658434/"
                },
                {
                    "xocs:funding-agency-matched-string": "Sanofi-Aventis",
                    "xocs:funding-agency": "Sanofi",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004339",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Merck Serono",
                    "xocs:funding-agency": "EMD Serono",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100004755",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Teva",
                    "xocs:funding-agency": "Teva Pharmaceutical Industries",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100006259",
                    "xocs:funding-agency-country": "http://sws.geonames.org/294640/"
                },
                {
                    "xocs:funding-agency-matched-string": "AbbVie",
                    "xocs:funding-agency": "AbbVie",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100006483",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "F. Hoffmann-La Roche Ltd.",
                    "xocs:funding-agency": "F. Hoffmann-La Roche",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100007013",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2658434/"
                },
                {
                    "xocs:funding-agency-matched-string": "Takeda",
                    "xocs:funding-agency-acronym": "TPUSA",
                    "xocs:funding-agency": "Takeda Pharmaceuticals U.S.A.",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100007723",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Janssen",
                    "xocs:funding-agency": "Janssen Pharmaceuticals",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100008897",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Merck Sharp & Dohme",
                    "xocs:funding-agency-acronym": "MSD",
                    "xocs:funding-agency": "Merck Sharp and Dohme",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100009947",
                    "xocs:funding-agency-country": "http://sws.geonames.org/2635167/"
                },
                {
                    "xocs:funding-agency-matched-string": "Clovis Oncology",
                    "xocs:funding-agency": "Clovis Oncology",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100014487",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Bayer",
                    "xocs:funding-agency-acronym": "BF",
                    "xocs:funding-agency": "Bayer Fund",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100015340",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Mirati Therapeutics Inc.",
                    "xocs:funding-agency": "Mirati Therapeutics",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100016957",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Incyte Corporation",
                    "xocs:funding-agency": "Incyte",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100017655",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Puma Biotechnology Inc.",
                    "xocs:funding-agency": "Puma Biotechnology",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100019402",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "G1 Therapeutics",
                    "xocs:funding-agency": "G1 Therapeutics",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100019799",
                    "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"
                },
                {
                    "xocs:funding-agency-matched-string": "Daiichi Sankyo",
                    "xocs:funding-agency": "Daiichi-Sankyo",
                    "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100002973",
                    "xocs:funding-agency-country": "http://sws.geonames.org/1861060/"
                }
            ],
            "xocs:funding-addon-generated-timestamp": "2022-11-16T11:58:38.059Z",
            "xocs:funding-text": [
                {"$": "Third-party medical writing assistance, under the direction of the authors, was provided by Nicola Griffin, BSc, and Fiona Fernando, PhD, of Ashfield MedComms, an Ashfield Health Company, and was funded by F. Hoffmann-La Roche Ltd. The authors thank Christine Malbeouf, Amy Donahue, Mark Kennedy, Travis Clark, Lauren Young, Virginia (Ginny) Breese, Lucas Dennis, and Ryan Woodhouse of Foundation Medicine Inc. for assay development and ALK-specific validation."},
                {"$": "Disclosure: Dr. Dziadziuszko reports receiving honoraria/consultancy fees from F. Hoffmann-La Roche Ltd., Pfizer, Boehringer Ingelheim, Bayer, Novartis, AstraZeneca, Merck Sharp & Dohme, Seattle Genetics, Foundation Medicine, and Takeda. Dr. Mok reports being compensated for a leadership role with AstraZeneca, Hutchison Chi-Med, Lunit USA, Inc., Aurora Tele-Oncology Ltd., and Sanomics Ltd.; receiving consultancy fees from AbbVie, ACEA Pharma, Alpha Biopharma Co. Ltd., Amgen, Amoy Diagnostics Co. Ltd., AstraZeneca, BeiGene, Berry Oncology, Boehringer Ingelheim, Blueprint Medicines, Bristol-Myers Squibb, CStone Pharmaceuticals, Curio Science, Daiichi Sankyo, Eisai, Fishawack Facilitate, Gritstone Oncology, Inc., Guardant Health, Hengrui Therapeutics Inc., Ignyta Inc., Incyte Corporation, Inivata, IQVIA, Janssen, Eli Lilly, Loxo Oncology, Lunit USA Inc., Merck Serono, Merck Sharpe & Dohme, Mirati Therapeutics Inc., MoreHealth, Novartis, OrigiMed, Pfizer, Puma Biotechnology Inc., Qiming Development (HK) Ltd., F. Hoffmann-La Roche Ltd./Genentech, Sanofi-Aventis, SFJ Pharmaceuticals Ltd., Takeda, Vertex Pharmaceuticals, and Yuhan Corporation; receiving honoraria from ACEA Pharma, Alpha Biopharma Co. Ltd., Amgen, Amoy Diagnostics Co. Ltd., AstraZeneca, BeiGene, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Fishawack Facilitate, InMed Medical Communication, Lilly, MD Health Brazil, Medscape, Merck Sharp & Dohme, Novartis, OrigiMed Co. Ltd., P. Permanyer SL, PeerVoice, Physicians\u2019 Education Resource, Pfizer, prIME Oncology, Research to Practice, F. Hoffmann-La Roche Ltd., Sanofi-Aventis, Shanghai BeBirds Translation & Consulting Co. Ltd., Liangyihui Network Technology Co. Ltd., Taiho, Takeda Oncology, and touchIME; receiving research funding from AstraZeneca, Bristol-Myers Squibb, G1 Therapeutics, F. Hoffmann-La Roche Ltd., Merck Sharp & Dohme, Merck Serono, Novartis, SFJ Pharmaceuticals, Pfizer, Takeda, and Xcovery; and owning stocks in Aurora Tele-Oncology Ltd., Hutchison Chi-Med, Sanomics Ltd., Lunit USA Inc., and Loxo Oncology. Dr. Peters reports to have received educational grants, provided consultation, attended advisory boards, and/or provided lectures for AbbVie, Amgen, AstraZeneca, Bayer, BeiGene, Biocartis, Boehringer Ingelheim, Bristol-Myers Squibb, Clovis Oncology, Daiichi Sankyo, Debiopharm, ecancer, Eli Lilly, Elsevier, F. Hoffmann-La Roche Ltd./Genentech, Foundation Medicine, Illumina, Imedex, IQVIA, Incyte, Janssen, Medscape, Merck Sharp & Dohme, Merck Serono, Merrimack, Novartis, Pharma Mar, Phosplatin Therapeutics, PER, Pfizer, PRIME, Regeneron, RTP, Sanofi, Seattle Genetics, and Takeda, from whom she has received honoraria; and to have received grants or research support ([sub]investigator in trials [institutional financial support for clinical trials]) from Amgen, AstraZeneca, Biodesix, Boehringer Ingelheim, Bristol-Myers Squibb, Clovis Oncology, F. Hoffmann-La Roche Ltd./Genentech, GlaxoSmithKline, Illumina, Eli Lilly, Merck Sharp & Dohme, Merck Serono, Mirati, Novartis, Pfizer, and Phosplatin Therapeutics. Dr. Han reports receiving honoraria from AstraZeneca, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Merck, Sharp & Dohme, and Takeda; having been compensated as an advisor for AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck Sharp & Dohme, Novartis, Pfizer, Takeda, Medpacto, Abion, and Ono; and receiving research grants from F. Hoffmann-La Roche Ltd., Pfizer, Takeda, and Ono. Dr. Alatorre-Alexander reports receiving honoraria/consultancy fees from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Lilly, Merck Sharp & Dohme, Novartis, Pfizer, F. Hoffmann-La Roche Ltd./Genentech, SFJ Pharmaceuticals, and Takeda; receiving payment for expert testimony from Merck Sharp & Dohme; receiving support for attending meetings and/or travel from AstraZeneca, Merck Sharp & Dohme, and F. Hoffmann-La Roche Ltd./Genentech; and participating on a data safety monitoring board or advisory board for AstraZeneca, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd./Genentech, and Merck Sharp & Dohme. Dr. Leighl reports receiving research funding from F. Hoffmann-La Roche Ltd., Array BioPharma, Guardant Health, and AstraZeneca; receiving honoraria and/or travel compensation for independent continuing medical education activities from AstraZeneca, Bristol-Myers Squibb, Merck Sharp & Dohme, F. Hoffmann-La Roche Ltd., and Pfizer; and having been a compensated advisor for Xcovery. Dr. Sriuranpong reports receiving honoraria/consultancy fees from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eisai, Eli Lilly, F. Hoffmann-La Roche Ltd., Merck Sharp & Dohme, Novartis, Pfizer, and Taiho Pharmaceutical; and receiving research funding through their Institution from AstraZeneca, Boehringer Ingelheim, F. Hoffmann-La Roche Ltd., Merck Sharp & Dohme, Novartis, Pfizer, Regeneron, and Taiho Pharmaceutical. Dr. Pérol reports receiving consultancy fees from Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, F. Hoffmann-La Roche Ltd., Gritstone, Merck Sharp & Dohme, Pfizer, and Takeda; receiving honoraria from Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Chugai, Eli Lilly, F. Hoffmann-La Roche Ltd., Illumina, Merck Sharp & Dohme, Pfizer, and Takeda; receiving support for attending meetings and/or travel from AstraZeneca, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Merck Sharp & Dohme, and Pfizer; and having participated on a data safety monitoring board or advisory board for F. Hoffmann-La Roche Ltd. Dr. de Castro Junior reports to having been compensated for a consulting/advisory role with AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Janssen, Merck Sharp & Dohme, Novartis, and Pfizer; participating in a speakers\u2019 bureau for AstraZeneca, Bayer, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Janssen, Merck Sharp & Dohme, Novartis, Pfizer, and Teva; receiving travel/accommodation and expenses from AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Merck Sharp & Dohme, Novartis, and Pfizer; and participating in a data safety monitoring board or advisory board for AstraZeneca, Bayer, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Janssen, Merck Sharp & Dohme, Novartis, Pfizer, and Teva. Dr. Nadal reports receiving honoraria/consultancy fees/lectures from Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Merck Serono, Merck Sharp & Dohme, Pfizer, and Takeda; and research funding from Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., and Merck Serono. Dr. de Marinis reports receiving honoraria from F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb, AstraZeneca, and Merck. Dr. Arén Frontera reports receiving honoraria from Bristol-Myers Squibb Chile. Dr. Tan reports receiving honoraria/consultancy fees from AstraZeneca, Bayer, Boehringer Ingelheim, Celgene, Eli Lilly, Loxo Oncology, Merck, Novartis, Pfizer, Roche, and Takeda; receiving research grants from AstraZeneca, Bayer, GlaxoSmithKline, Novartis, and Pfizer; and receiving travel or accommodation expenses from Boehringer Ingelheim, Merck, Novartis, Pfizer, Roche, and Takeda. Dr. Lee reports receiving honoraria/consultancy fees from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, CJ Healthcare, Eli Lilly, Chong Kun Dang, Janssen, Merck, Merck Sharp & Dohme, Mundipharma, Novartis, Ono, Pfizer, Roche, Samyang Biopharm, STCube Pharmaceuticals, AbbVie, Takeda, Genexine, and Menarini. Dr. Kim reports receiving honoraria/consultancy fees from AstraZeneca, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Ono, and Takeda. Dr. Yan is an employee of F. Hoffmann-La Roche Ltd. Dr. Riehl, Dr. Schleifman, Dr. Paul, Dr. Mocci, Dr. Patel, Dr. Assaf, Dr. Shames, and Dr. Mathisen are employees of Genentech, Inc. Dr. Riehl, Dr. Schleifman, and Dr. Paul also report owning stocks in F. Hoffmann-La Roche Ltd. Dr. Assaf also reports receiving support for attending meetings and/or travel from and owning stock in Genentech, Inc. Dr. Gadgeel reports receiving honoraria/consultancy fees from Takeda, AstraZeneca, Bristol-Myers Squibb, Xcovery, Boehringer Ingelheim, AbbVie, Novocure, Pfizer, Janssen, Eli Lilly, Merck, Blueprint Medicines, and F. Hoffmann-La Roche Ltd./Genentech and participating on a data safety monitoring board or advisory board for AstraZeneca."}
            ],
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Poland",
                            "@afid": "60012383",
                            "@country": "pol",
                            "city": "Gdansk",
                            "organization": [
                                {"$": "Department of Oncology and Radiotherapy"},
                                {"$": "Medical University of Gdansk"}
                            ],
                            "affiliation-id": {
                                "@afid": "60012383",
                                "@dptid": "109932679"
                            },
                            "@affiliation-instance-id": "S1556086421023212-b46cf6031e86e066f99b53ee7e1f6ad8",
                            "ce:source-text": "Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland",
                            "@dptid": "109932679"
                        },
                        "author": [{
                            "ce:given-name": "Rafal",
                            "preferred-name": {
                                "ce:given-name": "Rafal",
                                "ce:initials": "R.",
                                "ce:surname": "Dziadziuszko",
                                "ce:indexed-name": "Dziadziuszko R."
                            },
                            "@author-instance-id": "S1556086421023212-4ebe81ad28eb46e53f3f22dd49974f65",
                            "@seq": "1",
                            "ce:initials": "R.",
                            "@date-locked": "2022-11-14T02:05:14.087",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Dziadziuszko",
                            "@auid": "55888221300",
                            "ce:indexed-name": "Dziadziuszko R."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Hong Kong",
                            "@afid": "60002798",
                            "@country": "hkg",
                            "city": "Shatin",
                            "organization": [
                                {"$": "State Key Laboratory of Translational Oncology"},
                                {"$": "Chinese University of Hong Kong"}
                            ],
                            "affiliation-id": {"@afid": "60002798"},
                            "@affiliation-instance-id": "S1556086421023212-97978d8f2195ed8aa88b4ccc1e3436c0",
                            "ce:source-text": "State Key Laboratory of Translational Oncology, Chinese University of Hong Kong, Shatin, Hong Kong"
                        },
                        "author": [{
                            "ce:given-name": "Tony",
                            "preferred-name": {
                                "ce:given-name": "Tony",
                                "ce:initials": "T.",
                                "ce:surname": "Mok",
                                "ce:indexed-name": "Mok T."
                            },
                            "@author-instance-id": "S1556086421023212-719010a5bce7f2fb6cc2b960182e8ec3",
                            "@seq": "2",
                            "ce:initials": "T.",
                            "@date-locked": "2023-04-07T23:25:24.740",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Mok",
                            "@auid": "7006561460",
                            "ce:indexed-name": "Mok T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Switzerland",
                            "@afid": "60023561",
                            "@country": "che",
                            "organization": [
                                {"$": "Oncology Department"},
                                {"$": "University Hospital (CHUV)"},
                                {"$": "University of Lausanne"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60023561",
                                    "@dptid": "113497458"
                                },
                                {"@afid": "60000239"}
                            ],
                            "@affiliation-instance-id": "S1556086421023212-b156eab69d57a1c7a1090c899a0376f1",
                            "ce:source-text": "Oncology Department, University Hospital (CHUV), University of Lausanne, Switzerland",
                            "@dptid": "113497458"
                        },
                        "author": [{
                            "ce:given-name": "Solange",
                            "preferred-name": {
                                "ce:given-name": "Solange",
                                "ce:initials": "S.",
                                "ce:surname": "Peters",
                                "ce:indexed-name": "Peters S."
                            },
                            "@author-instance-id": "S1556086421023212-e306652d139df7194080b545074173d1",
                            "@seq": "3",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD, PhD",
                            "ce:surname": "Peters",
                            "@auid": "57218315686",
                            "ce:indexed-name": "Peters S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60068716",
                            "@country": "kor",
                            "city": "Goyang",
                            "organization": [
                                {"$": "Center for Lung Cancer"},
                                {"$": "National Cancer Center"}
                            ],
                            "affiliation-id": {
                                "@afid": "60068716",
                                "@dptid": "104742898"
                            },
                            "@affiliation-instance-id": "S1556086421023212-24f28c60537ff52a8925958795f25850",
                            "ce:source-text": "Center for Lung Cancer, National Cancer Center, Goyang, South Korea",
                            "@dptid": "104742898"
                        },
                        "author": [{
                            "ce:given-name": "Ji-Youn",
                            "preferred-name": {
                                "ce:given-name": "Ji Youn",
                                "ce:initials": "J.Y.",
                                "ce:surname": "Han",
                                "ce:indexed-name": "Han J.Y."
                            },
                            "@author-instance-id": "S1556086421023212-555dfd5cb0a6d3733091aa641496aea5",
                            "@seq": "4",
                            "ce:initials": "J.-Y.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD, PhD",
                            "ce:surname": "Han",
                            "@auid": "18042023400",
                            "ce:indexed-name": "Han J.-Y."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Mexico",
                            "@afid": "124797096",
                            "@country": "mex",
                            "city": "Mexico City",
                            "organization": [
                                {"$": "Thoracic Oncology Clinic"},
                                {"$": "Health Pharma Professional Research"}
                            ],
                            "affiliation-id": {
                                "@afid": "124797096",
                                "@dptid": "125927781"
                            },
                            "@affiliation-instance-id": "S1556086421023212-9b1016fce81ccafcb39b429e5bbf7e4a",
                            "ce:source-text": "Health Pharma Professional Research, Mexico City, Mexico",
                            "@dptid": "125927781"
                        },
                        "author": [{
                            "ce:given-name": "Jorge",
                            "preferred-name": {
                                "ce:given-name": "Jorge",
                                "ce:initials": "J.",
                                "ce:surname": "Alatorre-Alexander",
                                "ce:indexed-name": "Alatorre-Alexander J."
                            },
                            "@author-instance-id": "S1556086421023212-52134f20d0d410d526966e7cafc0f090",
                            "@seq": "5",
                            "ce:initials": "J.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Alatorre-Alexander",
                            "@auid": "55736184300",
                            "ce:indexed-name": "Alatorre-Alexander J."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Canada",
                            "@afid": "60027817",
                            "@country": "can",
                            "city": "Toronto",
                            "organization": [
                                {"$": "Division of Medical Oncology"},
                                {"$": "Princess Margaret Cancer Centre"}
                            ],
                            "affiliation-id": {
                                "@afid": "60027817",
                                "@dptid": "109706505"
                            },
                            "state": "ON",
                            "@affiliation-instance-id": "S1556086421023212-94e16b5af783546145bb47a509a9a319",
                            "ce:source-text": "Princess Margaret Cancer Centre, Toronto, Ontario, Canada",
                            "@dptid": "109706505"
                        },
                        "author": [{
                            "ce:given-name": "Natasha",
                            "preferred-name": {
                                "ce:given-name": "Natasha",
                                "ce:initials": "N.",
                                "ce:surname": "Leighl",
                                "ce:indexed-name": "Leighl N."
                            },
                            "@author-instance-id": "S1556086421023212-4105f2ae1bea3ee9a5d9f6638e0bb518",
                            "@seq": "6",
                            "ce:initials": "N.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Leighl",
                            "@auid": "6602944827",
                            "ce:indexed-name": "Leighl N."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60022183",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University and the King Chulalongkorn Memorial Hospital"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60022183",
                                    "@dptid": "104136204"
                                },
                                {"@afid": "60028190"}
                            ],
                            "@affiliation-instance-id": "S1556086421023212-2676213816437d3c5d87539dbd96934d",
                            "ce:source-text": "Faculty of Medicine, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, Thailand",
                            "@dptid": "104136204"
                        },
                        "author": [{
                            "ce:given-name": "Virote",
                            "preferred-name": {
                                "ce:given-name": "Virote",
                                "ce:initials": "V.",
                                "ce:surname": "Sriuranpong",
                                "ce:indexed-name": "Sriuranpong V."
                            },
                            "@author-instance-id": "S1556086421023212-22e218eaadcaddaa8706ccf781a93102",
                            "@seq": "7",
                            "ce:initials": "V.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Sriuranpong",
                            "@auid": "6603599644",
                            "ce:indexed-name": "Sriuranpong V."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "France",
                            "@afid": "60018084",
                            "@country": "fra",
                            "city": "Lyon",
                            "organization": [
                                {"$": "Department of Medical Oncology"},
                                {"$": "Léon Bérard Cancer Center"}
                            ],
                            "affiliation-id": {
                                "@afid": "60018084",
                                "@dptid": "113882509"
                            },
                            "@affiliation-instance-id": "S1556086421023212-71286781198087c658b490c906358d5d",
                            "ce:source-text": "Department of Medical Oncology, Leon Berard Cancer Center, Lyon, France",
                            "@dptid": "113882509"
                        },
                        "author": [{
                            "ce:given-name": "Maurice",
                            "preferred-name": {
                                "ce:given-name": "Maurice",
                                "ce:initials": "M.",
                                "ce:surname": "Pérol",
                                "ce:indexed-name": "Pérol M."
                            },
                            "@author-instance-id": "S1556086421023212-bfcbb12b652744303382ffb6cea9bbeb",
                            "@seq": "8",
                            "ce:initials": "M.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Pérol",
                            "@auid": "7006708830",
                            "ce:indexed-name": "Perol M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Brazil",
                            "@afid": "60008088",
                            "@country": "bra",
                            "city": "São Paulo",
                            "organization": [
                                {"$": "Division of Clinical Oncology"},
                                {"$": "Instituto do Cancer do Estado de São Paulo"}
                            ],
                            "affiliation-id": {
                                "@afid": "60008088",
                                "@dptid": "108500310"
                            },
                            "@affiliation-instance-id": "S1556086421023212-0ed1774f71622799fd005ce8ae32392d",
                            "ce:source-text": "Instituto do Cancer do Estado de Sao Paulo, Sao Paulo, Brazil",
                            "@dptid": "108500310"
                        },
                        "author": [{
                            "ce:given-name": "Gilberto",
                            "preferred-name": {
                                "ce:given-name": "Gilberto",
                                "ce:initials": "G.",
                                "ce:surname": "de Castro Junior",
                                "ce:indexed-name": "de Castro Junior G."
                            },
                            "@author-instance-id": "S1556086421023212-eae03a7fb5d55cb573a8b6f8c04c37d3",
                            "@seq": "9",
                            "ce:initials": "G.",
                            "@date-locked": "2022-12-29T03:23:56.819",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD, PhD",
                            "ce:surname": "de Castro Junior",
                            "@auid": "57211774389",
                            "ce:indexed-name": "de Castro Junior G."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Spain",
                            "@afid": "60015633",
                            "@country": "esp",
                            "city": "Barcelona",
                            "organization": [
                                {"$": "Catalan Institute of Oncology"},
                                {"$": "L'Hospitalet"}
                            ],
                            "affiliation-id": {"@afid": "60015633"},
                            "@affiliation-instance-id": "S1556086421023212-7ab17dacef151556cd699f6eeb6450fb",
                            "ce:source-text": "Catalan Institute of Oncology, L'Hospitalet, Barcelona, Spain"
                        },
                        "author": [{
                            "ce:given-name": "Ernest",
                            "preferred-name": {
                                "ce:given-name": "Ernest",
                                "ce:initials": "E.",
                                "ce:surname": "Nadal",
                                "ce:indexed-name": "Nadal E."
                            },
                            "@author-instance-id": "S1556086421023212-68783fb0990c0dd5edabb12e11828a9e",
                            "@seq": "10",
                            "ce:initials": "E.",
                            "@date-locked": "2022-10-10T13:36:42.341",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Nadal",
                            "@auid": "36619073100",
                            "ce:indexed-name": "Nadal E."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Italy",
                            "@afid": "60030442",
                            "@country": "ita",
                            "city": "Milan",
                            "organization": [
                                {"$": "European Institute of Oncology"},
                                {"$": "Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)"}
                            ],
                            "affiliation-id": {"@afid": "60030442"},
                            "@affiliation-instance-id": "S1556086421023212-9d3f00accbda083a59a62eb4df6539e1",
                            "ce:source-text": "European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy"
                        },
                        "author": [{
                            "ce:given-name": "Filippo",
                            "preferred-name": {
                                "ce:given-name": "Filippo",
                                "ce:initials": "F.",
                                "ce:surname": "de Marinis",
                                "ce:indexed-name": "de Marinis F."
                            },
                            "@author-instance-id": "S1556086421023212-96d2396c455797160d6f2e6fecc44fe3",
                            "@seq": "11",
                            "ce:initials": "F.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "de Marinis",
                            "@auid": "56273853600",
                            "ce:indexed-name": "de Marinis F."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Chile",
                            "@afid": "121490051",
                            "@country": "chl",
                            "city": "Santiago",
                            "organization": {"$": "Centro de Investigación Clínica Bradford Hill"},
                            "affiliation-id": {"@afid": "121490051"},
                            "@affiliation-instance-id": "S1556086421023212-edaa4db7fd8fce05f54d0d83709a42d6",
                            "ce:source-text": "Centro de Investigacion Clinica Bradford Hill, Santiago, Chile"
                        },
                        "author": [{
                            "ce:given-name": "Osvaldo Arén",
                            "preferred-name": {
                                "ce:given-name": "Osvaldo Arén",
                                "ce:initials": "O.A.",
                                "ce:surname": "Frontera",
                                "ce:indexed-name": "Frontera O.A."
                            },
                            "@author-instance-id": "S1556086421023212-8bcaa58d93b228c78daffbd2196ade82",
                            "@seq": "12",
                            "ce:initials": "O.A.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Frontera",
                            "@auid": "56716391100",
                            "ce:indexed-name": "Frontera O.A."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Singapore",
                            "@afid": "60031809",
                            "@country": "sgp",
                            "organization": [
                                {"$": "Division of Medical Oncology"},
                                {"$": "National Cancer Centre Singapore"}
                            ],
                            "affiliation-id": {
                                "@afid": "60031809",
                                "@dptid": "104614771"
                            },
                            "@affiliation-instance-id": "S1556086421023212-daf0da3243aaacd158f11a10f5858541",
                            "ce:source-text": "National Cancer Centre Singapore, Singapore",
                            "@dptid": "104614771"
                        },
                        "author": [{
                            "ce:given-name": "Daniel S.W.",
                            "preferred-name": {
                                "ce:given-name": "Daniel S.W.",
                                "ce:initials": "D.S.W.",
                                "ce:surname": "Tan",
                                "ce:indexed-name": "Tan D.S.W."
                            },
                            "@author-instance-id": "S1556086421023212-e150cde7ae291a244ad3664b00e104c9",
                            "@seq": "13",
                            "ce:initials": "D.S.W.",
                            "@date-locked": "2023-06-24T18:11:27.474",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Tan",
                            "@auid": "25931213800",
                            "ce:indexed-name": "Tan D.S.W."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60006240",
                            "@country": "kor",
                            "city": "Seoul",
                            "organization": [
                                {"$": "Asan Medical Center"},
                                {"$": "University of Ulsan College of Medicine"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60006240"},
                                {"@afid": "60068691"}
                            ],
                            "@affiliation-instance-id": "S1556086421023212-fb7df1bf376bb27fce526b042440a15b",
                            "ce:source-text": "Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea"
                        },
                        "author": [{
                            "ce:given-name": "Dae Ho",
                            "preferred-name": {
                                "ce:given-name": "Dae Ho",
                                "ce:initials": "D.H.",
                                "ce:surname": "Lee",
                                "ce:indexed-name": "Lee D.H."
                            },
                            "@author-instance-id": "S1556086421023212-e3e19404f8fa7998925c336a41f5f728",
                            "@seq": "14",
                            "ce:initials": "D.H.",
                            "@date-locked": "2022-12-05T21:30:42.868",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Lee",
                            "@auid": "16401931900",
                            "ce:indexed-name": "Lee D.H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "South Korea",
                            "@afid": "60115402",
                            "@country": "kor",
                            "city": "Seoul",
                            "organization": [
                                {"$": "Division of Medical Oncology"},
                                {"$": "Department of Internal Medicine"},
                                {"$": "Yonsei Cancer Centre"},
                                {"$": "Yonsei University College of Medicine"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60115402",
                                    "@dptid": "122182845"
                                },
                                {"@afid": "60016728"}
                            ],
                            "@affiliation-instance-id": "S1556086421023212-002855970c9f4dc32eff334b1c1819c3",
                            "ce:source-text": "Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Centre, Yonsei University College of Medicine, Seoul, South Korea",
                            "@dptid": "122182845"
                        },
                        "author": [{
                            "ce:given-name": "Hye Ryun",
                            "preferred-name": {
                                "ce:given-name": "Hye Ryun",
                                "ce:initials": "H.R.",
                                "ce:surname": "Kim",
                                "ce:indexed-name": "Kim H.R."
                            },
                            "@author-instance-id": "S1556086421023212-aed311afbe0c3f2c174fab2deb7b330e",
                            "@seq": "15",
                            "ce:initials": "H.R.",
                            "@date-locked": "2021-10-21T08:22:21.601",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD, PhD",
                            "ce:surname": "Kim",
                            "@auid": "8583782700",
                            "ce:indexed-name": "Kim H.R."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Canada",
                            "@afid": "100363548",
                            "@country": "can",
                            "city": "Mississauga",
                            "organization": {"$": "F. Hoffmann-La Roche"},
                            "affiliation-id": {"@afid": "100363548"},
                            "@affiliation-instance-id": "S1556086421023212-4f2151c266b11dbe3212d1832562ef86",
                            "ce:source-text": "F. Hoffmann-La Roche, Mississauga, Canada"
                        },
                        "author": [{
                            "ce:given-name": "Mark",
                            "preferred-name": {
                                "ce:given-name": "Mark",
                                "ce:initials": "M.",
                                "ce:surname": "Yan",
                                "ce:indexed-name": "Yan M."
                            },
                            "@author-instance-id": "S1556086421023212-c514460b1b14b8afb60d3a003bd89751",
                            "@seq": "16",
                            "ce:initials": "M.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "PhD",
                            "ce:surname": "Yan",
                            "@auid": "57468482900",
                            "ce:indexed-name": "Yan M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "address-part": "South San Francisco",
                            "@afid": "60026209",
                            "@country": "usa",
                            "organization": [
                                {"$": "Genentech"},
                                {"$": "Inc."}
                            ],
                            "affiliation-id": {"@afid": "60026209"},
                            "state": "CA",
                            "@affiliation-instance-id": "S1556086421023212-91db692ffd372bfe5a10255a56db4bd1",
                            "ce:source-text": "Genentech, Inc., South San Francisco, California"
                        },
                        "author": [
                            {
                                "ce:given-name": "Todd",
                                "preferred-name": {
                                    "ce:given-name": "Todd",
                                    "ce:initials": "T.",
                                    "ce:surname": "Riehl",
                                    "ce:indexed-name": "Riehl T."
                                },
                                "@author-instance-id": "S1556086421023212-c25b6b1a7fa017cb7036f575e86917f6",
                                "@seq": "17",
                                "ce:initials": "T.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "PharmD",
                                "ce:surname": "Riehl",
                                "@auid": "57191887645",
                                "ce:indexed-name": "Riehl T."
                            },
                            {
                                "ce:given-name": "Erica",
                                "preferred-name": {
                                    "ce:given-name": "Erica",
                                    "ce:initials": "E.",
                                    "ce:surname": "Schleifman",
                                    "ce:indexed-name": "Schleifman E."
                                },
                                "@author-instance-id": "S1556086421023212-790fc6813bce64791c60827a0f76f2c1",
                                "@seq": "18",
                                "ce:initials": "E.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "PhD",
                                "ce:surname": "Schleifman",
                                "@auid": "16680398700",
                                "ce:indexed-name": "Schleifman E."
                            },
                            {
                                "ce:given-name": "Sarah M.",
                                "preferred-name": {
                                    "ce:given-name": "Sarah M.",
                                    "ce:initials": "S.M.",
                                    "ce:surname": "Paul",
                                    "ce:indexed-name": "Paul S.M."
                                },
                                "@author-instance-id": "S1556086421023212-9ca929ebcedbcac4a4c3aa6afb816ef7",
                                "@seq": "19",
                                "ce:initials": "S.M.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "PhD",
                                "ce:surname": "Paul",
                                "@auid": "57203640779",
                                "ce:indexed-name": "Paul S.M."
                            },
                            {
                                "ce:given-name": "Simonetta",
                                "preferred-name": {
                                    "ce:given-name": "Simonetta",
                                    "ce:initials": "S.",
                                    "ce:surname": "Mocci",
                                    "ce:indexed-name": "Mocci S."
                                },
                                "@author-instance-id": "S1556086421023212-7da688d11c90d1f7c6d5ba2fa6608453",
                                "@seq": "20",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD, PhD",
                                "ce:surname": "Mocci",
                                "@auid": "56462674500",
                                "ce:indexed-name": "Mocci S."
                            },
                            {
                                "ce:given-name": "Rajesh",
                                "preferred-name": {
                                    "ce:given-name": "Rajesh",
                                    "ce:initials": "R.",
                                    "ce:surname": "Patel",
                                    "ce:indexed-name": "Patel R."
                                },
                                "@author-instance-id": "S1556086421023212-fb8daddc8b0cd6a17bbebfff5f759e81",
                                "@seq": "21",
                                "ce:initials": "R.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "PhD",
                                "ce:surname": "Patel",
                                "@auid": "55472426800",
                                "ce:indexed-name": "Patel R."
                            },
                            {
                                "ce:given-name": "Zoe June",
                                "preferred-name": {
                                    "ce:given-name": "Zoe June",
                                    "ce:initials": "Z.J.",
                                    "ce:surname": "Assaf",
                                    "ce:indexed-name": "Assaf Z.J."
                                },
                                "@author-instance-id": "S1556086421023212-64b67f5f88d6edfff6d97a6a6d335298",
                                "@seq": "22",
                                "ce:initials": "Z.J.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "PhD",
                                "ce:surname": "Assaf",
                                "@auid": "57220095134",
                                "ce:indexed-name": "Assaf Z.J."
                            },
                            {
                                "ce:given-name": "David S.",
                                "preferred-name": {
                                    "ce:given-name": "David S.",
                                    "ce:initials": "D.S.",
                                    "ce:surname": "Shames",
                                    "ce:indexed-name": "Shames D.S."
                                },
                                "@author-instance-id": "S1556086421023212-cb9a806a8c3e4b85f6d5154457d2a488",
                                "@seq": "23",
                                "ce:initials": "D.S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "PhD",
                                "ce:surname": "Shames",
                                "@auid": "34573130000",
                                "ce:indexed-name": "Shames D.S."
                            },
                            {
                                "ce:given-name": "Michael S.",
                                "preferred-name": {
                                    "ce:given-name": "Michael S.",
                                    "ce:initials": "M.S.",
                                    "ce:surname": "Mathisen",
                                    "ce:indexed-name": "Mathisen M.S."
                                },
                                "@author-instance-id": "S1556086421023212-67b8d8fab92123f61ac56d375448f408",
                                "@seq": "24",
                                "ce:initials": "M.S.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "PharmD",
                                "ce:surname": "Mathisen",
                                "@auid": "37091097200",
                                "ce:indexed-name": "Mathisen M.S."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "@afid": "60030704",
                            "@country": "usa",
                            "city": "Detroit",
                            "organization": [
                                {"$": "Department of Internal Medicine"},
                                {"$": "Henry Ford Cancer Institute"},
                                {"$": "Henry Ford Health System"}
                            ],
                            "affiliation-id": {
                                "@afid": "60030704",
                                "@dptid": "113531496"
                            },
                            "state": "MI",
                            "@affiliation-instance-id": "S1556086421023212-e5f038f4b2be83e89103d495708558be",
                            "ce:source-text": "Department of Internal Medicine, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, Michigan",
                            "@dptid": "113531496"
                        },
                        "author": [{
                            "ce:given-name": "Shirish M.",
                            "preferred-name": {
                                "ce:given-name": "Shirish M.",
                                "ce:initials": "S.M.",
                                "ce:surname": "Gadgeel",
                                "ce:indexed-name": "Gadgeel S.M."
                            },
                            "@author-instance-id": "S1556086421023212-18536eea82d01efa2ee5a2079e131f4e",
                            "@seq": "25",
                            "ce:initials": "S.M.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Gadgeel",
                            "@auid": "6603479165",
                            "ce:indexed-name": "Gadgeel S.M."
                        }]
                    }
                ],
                "citation-title": "Blood First Assay Screening Trial (BFAST) in Treatment-Naive Advanced or Metastatic NSCLC: Initial Results of the Phase 2 ALK-Positive Cohort",
                "abstracts": "© 2021 International Association for the Study of Lung CancerIntroduction: The Blood First Assay Screening Trial is an ongoing open-label, multicohort study, prospectively evaluating the relationship between blood-based next-generation sequencing (NGS) detection of actionable genetic alterations and activity of targeted therapies or immunotherapy in treatment-naive advanced or metastatic NSCLC. We present data from the ALK-positive cohort. Methods: Patients aged more than or equal to 18 years with stage IIIB or IV NSCLC and ALK rearrangements detected by blood-based NGS using hybrid capture technology (FoundationACT) received alectinib 600 mg twice daily. Asymptomatic or treated central nervous system (CNS) metastases were permitted. Primary end point was investigator-assessed objective response rate (ORR; Response Evaluation Criteria in Solid Tumors version 1.1). Secondary end points were independent review facility-assessed ORR, duration of response, progression-free survival (PFS), overall survival, and safety. Exploratory end points were investigator-assessed ORR in patients with baseline CNS metastases and relationship between circulating biomarkers and response. Results: In total, 2219 patients were screened and blood-based NGS yielded results in 98.6% of the cases. Of these, 119 patients (5.4%) had ALK-positive disease; 87 were enrolled and received alectinib. Median follow-up was 12.6 months (range: 2.6\u201318.7). Confirmed ORR was 87.4% (95% confidence interval [CI]: 78.5\u201393.5) by investigator and 92.0% (95% CI: 84.1\u201396.7) by independent review facility. Investigator-confirmed 12-month duration of response was 75.9% (95% CI: 63.6\u201388.2). In 35 patients (40%) with baseline CNS disease, investigator-assessed ORR was 91.4% (95% CI: 76.9\u201398.2). Median PFS was not reached; 12-month investigator-assessed PFS was 78.4% (95% CI: 69.1\u201387.7). Safety data were consistent with the known tolerability profile of alectinib. Conclusions: These results reveal the clinical application of blood-based NGS as a method to inform clinical decision-making in ALK-positive NSCLC.",
                "correspondence": {
                    "affiliation": {
                        "country": "United States",
                        "address-part": "2800 West Grand Boulevard",
                        "postal-code": "48202",
                        "@country": "usa",
                        "city": "Detroit",
                        "organization": [
                            {"$": "Department of Internal Medicine"},
                            {"$": "Henry Ford Cancer Institute"},
                            {"$": "Henry Ford Health System"}
                        ],
                        "state": "MI"
                    },
                    "person": {
                        "ce:given-name": "Shirish M.",
                        "ce:initials": "S.M.",
                        "ce:degrees": "MD",
                        "ce:surname": "Gadgeel",
                        "ce:indexed-name": "Gadgeel S.M."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "Alectinib",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "ALK-positive",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Blood-based assay",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "Next-generation sequencing",
                            "@xml:lang": "eng",
                            "@original": "y"
                        },
                        {
                            "$": "NSCLC",
                            "@xml:lang": "eng",
                            "@original": "y"
                        }
                    ]},
                    "citation-type": {"@code": "cp"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "sourcetitle-abbrev": "J. Thorac. Oncol.",
                    "website": {"ce:e-address": {
                        "$": "https://www.journals.elsevier.com/journal-of-thoracic-oncology/",
                        "@type": "email"
                    }},
                    "@country": "usa",
                    "translated-sourcetitle": {
                        "$": "Journal of Thoracic Oncology",
                        "@xml:lang": "eng"
                    },
                    "issn": [
                        {
                            "$": "15561380",
                            "@type": "electronic"
                        },
                        {
                            "$": "15560864",
                            "@type": "print"
                        }
                    ],
                    "volisspag": {
                        "voliss": {
                            "@volume": "16",
                            "@issue": "12"
                        },
                        "pagerange": {
                            "@first": "2040",
                            "@last": "2050"
                        }
                    },
                    "@type": "j",
                    "publicationyear": {"@first": "2021"},
                    "publisher": {"publishername": "Elsevier Inc."},
                    "sourcetitle": "Journal of Thoracic Oncology",
                    "@srcid": "6400153137",
                    "publicationdate": {
                        "month": "12",
                        "year": "2021",
                        "date-text": "December 2021",
                        "day": "01"
                    }
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "15",
                                    "classification-description": "Chest Diseases, Thoracic Surgery and Tuberculosis"
                                },
                                {
                                    "classification-code": "16",
                                    "classification-description": "Cancer"
                                },
                                {
                                    "classification-code": "22",
                                    "classification-description": "Human Genetics"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "38",
                                    "classification-description": "Adverse Reactions Titles"
                                },
                                {
                                    "classification-code": "8",
                                    "classification-description": "Neurology and Neurosurgery"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "2730"},
                                {"$": "2740"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": [
                                        {"$": "9000-86-6"},
                                        {"$": "9014-30-6"}
                                    ],
                                    "enzyme-commission-number": "EC 2.6.1.2",
                                    "chemical-name": "alanine aminotransferase"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "1256580-46-7"},
                                        {"$": "1256589-74-8"}
                                    ],
                                    "chemical-name": "alectinib"
                                },
                                {
                                    "cas-registry-number": "166433-56-3",
                                    "chemical-name": "anaplastic lymphoma kinase"
                                },
                                {
                                    "cas-registry-number": "9000-97-9",
                                    "enzyme-commission-number": "EC 2.6.1.1",
                                    "chemical-name": "aspartate aminotransferase"
                                },
                                {
                                    "cas-registry-number": "1380723-44-3",
                                    "chemical-name": "atezolizumab"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "216974-75-3"},
                                        {"$": "1438851-35-4"}
                                    ],
                                    "chemical-name": "bevacizumab"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "18422-02-1"},
                                        {"$": "635-65-4"}
                                    ],
                                    "chemical-name": "bilirubin"
                                },
                                {
                                    "cas-registry-number": "41575-94-4",
                                    "chemical-name": "carboplatin"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "934660-93-2"},
                                        {"$": "1369665-02-0"}
                                    ],
                                    "chemical-name": "cobimetinib"
                                },
                                {
                                    "cas-registry-number": "9001-15-4",
                                    "enzyme-commission-number": "EC 2.7.3.2",
                                    "chemical-name": "creatine kinase"
                                },
                                {
                                    "cas-registry-number": "1108743-60-7",
                                    "chemical-name": "entrectinib"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "137281-23-3"},
                                        {"$": "150399-23-8"},
                                        {"$": "357166-30-4"},
                                        {"$": "357166-29-1"}
                                    ],
                                    "chemical-name": "pemetrexed"
                                },
                                {
                                    "cas-registry-number": "918504-65-1",
                                    "chemical-name": "vemurafenib"
                                },
                                {
                                    "cas-registry-number": "877399-52-5",
                                    "chemical-name": "crizotinib"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Anaplastic Lymphoma Kinase"},
                                {"chemical-name": "Crizotinib"},
                                {"chemical-name": "Protein Kinase Inhibitors"}
                            ]
                        }
                    ]}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "Disclosure: Dr. Dziadziuszko reports receiving honoraria/consultancy fees from F. Hoffmann-La Roche Ltd., Pfizer, Boehringer Ingelheim, Bayer, Novartis, AstraZeneca, Merck Sharp & Dohme, Seattle Genetics, Foundation Medicine, and Takeda. Dr. Mok reports being compensated for a leadership role with AstraZeneca, Hutchison Chi-Med, Lunit USA, Inc., Aurora Tele-Oncology Ltd., and Sanomics Ltd.; receiving consultancy fees from AbbVie, ACEA Pharma, Alpha Biopharma Co. Ltd., Amgen, Amoy Diagnostics Co. Ltd., AstraZeneca, BeiGene, Berry Oncology, Boehringer Ingelheim, Blueprint Medicines, Bristol-Myers Squibb, CStone Pharmaceuticals, Curio Science, Daiichi Sankyo, Eisai, Fishawack Facilitate, Gritstone Oncology, Inc., Guardant Health, Hengrui Therapeutics Inc., Ignyta Inc., Incyte Corporation, Inivata, IQVIA, Janssen, Eli Lilly, Loxo Oncology, Lunit USA Inc., Merck Serono, Merck Sharpe & Dohme, Mirati Therapeutics Inc., MoreHealth, Novartis, OrigiMed, Pfizer, Puma Biotechnology Inc., Qiming Development (HK) Ltd., F. Hoffmann-La Roche Ltd./Genentech, Sanofi-Aventis, SFJ Pharmaceuticals Ltd., Takeda, Vertex Pharmaceuticals, and Yuhan Corporation; receiving honoraria from ACEA Pharma, Alpha Biopharma Co. Ltd., Amgen, Amoy Diagnostics Co. Ltd., AstraZeneca, BeiGene, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Fishawack Facilitate, InMed Medical Communication, Lilly, MD Health Brazil, Medscape, Merck Sharp & Dohme, Novartis, OrigiMed Co. Ltd., P. Permanyer SL, PeerVoice, Physicians\u2019 Education Resource, Pfizer, prIME Oncology, Research to Practice, F. Hoffmann-La Roche Ltd., Sanofi-Aventis, Shanghai BeBirds Translation & Consulting Co. Ltd., Liangyihui Network Technology Co. Ltd., Taiho, Takeda Oncology, and touchIME; receiving research funding from AstraZeneca, Bristol-Myers Squibb, G1 Therapeutics, F. Hoffmann-La Roche Ltd., Merck Sharp & Dohme, Merck Serono, Novartis, SFJ Pharmaceuticals, Pfizer, Takeda, and Xcovery; and owning stocks in Aurora Tele-Oncology Ltd., Hutchison Chi-Med, Sanomics Ltd., Lunit USA Inc., and Loxo Oncology. Dr. Peters reports to have received educational grants, provided consultation, attended advisory boards, and/or provided lectures for AbbVie, Amgen, AstraZeneca, Bayer, BeiGene, Biocartis, Boehringer Ingelheim, Bristol-Myers Squibb, Clovis Oncology, Daiichi Sankyo, Debiopharm, ecancer, Eli Lilly, Elsevier, F. Hoffmann-La Roche Ltd./Genentech, Foundation Medicine, Illumina, Imedex, IQVIA, Incyte, Janssen, Medscape, Merck Sharp & Dohme, Merck Serono, Merrimack, Novartis, Pharma Mar, Phosplatin Therapeutics, PER, Pfizer, PRIME, Regeneron, RTP, Sanofi, Seattle Genetics, and Takeda, from whom she has received honoraria; and to have received grants or research support ([sub]investigator in trials [institutional financial support for clinical trials]) from Amgen, AstraZeneca, Biodesix, Boehringer Ingelheim, Bristol-Myers Squibb, Clovis Oncology, F. Hoffmann-La Roche Ltd./Genentech, GlaxoSmithKline, Illumina, Eli Lilly, Merck Sharp & Dohme, Merck Serono, Mirati, Novartis, Pfizer, and Phosplatin Therapeutics. Dr. Han reports receiving honoraria from AstraZeneca, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Merck, Sharp & Dohme, and Takeda; having been compensated as an advisor for AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck Sharp & Dohme, Novartis, Pfizer, Takeda, Medpacto, Abion, and Ono; and receiving research grants from F. Hoffmann-La Roche Ltd., Pfizer, Takeda, and Ono. Dr. Alatorre-Alexander reports receiving honoraria/consultancy fees from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Lilly, Merck Sharp & Dohme, Novartis, Pfizer, F. Hoffmann-La Roche Ltd./Genentech, SFJ Pharmaceuticals, and Takeda; receiving payment for expert testimony from Merck Sharp & Dohme; receiving support for attending meetings and/or travel from AstraZeneca, Merck Sharp & Dohme, and F. Hoffmann-La Roche Ltd./Genentech; and participating on a data safety monitoring board or advisory board for AstraZeneca, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd./Genentech, and Merck Sharp & Dohme. Dr. Leighl reports receiving research funding from F. Hoffmann-La Roche Ltd., Array BioPharma, Guardant Health, and AstraZeneca; receiving honoraria and/or travel compensation for independent continuing medical education activities from AstraZeneca, Bristol-Myers Squibb, Merck Sharp & Dohme, F. Hoffmann-La Roche Ltd., and Pfizer; and having been a compensated advisor for Xcovery. Dr. Sriuranpong reports receiving honoraria/consultancy fees from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eisai, Eli Lilly, F. Hoffmann-La Roche Ltd., Merck Sharp & Dohme, Novartis, Pfizer, and Taiho Pharmaceutical; and receiving research funding through their Institution from AstraZeneca, Boehringer Ingelheim, F. Hoffmann-La Roche Ltd., Merck Sharp & Dohme, Novartis, Pfizer, Regeneron, and Taiho Pharmaceutical. Dr. Pérol reports receiving consultancy fees from Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, F. Hoffmann-La Roche Ltd., Gritstone, Merck Sharp & Dohme, Pfizer, and Takeda; receiving honoraria from Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Chugai, Eli Lilly, F. Hoffmann-La Roche Ltd., Illumina, Merck Sharp & Dohme, Pfizer, and Takeda; receiving support for attending meetings and/or travel from AstraZeneca, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Merck Sharp & Dohme, and Pfizer; and having participated on a data safety monitoring board or advisory board for F. Hoffmann-La Roche Ltd. Dr. de Castro Junior reports to having been compensated for a consulting/advisory role with AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Janssen, Merck Sharp & Dohme, Novartis, and Pfizer; participating in a speakers\u2019 bureau for AstraZeneca, Bayer, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Janssen, Merck Sharp & Dohme, Novartis, Pfizer, and Teva; receiving travel/accommodation and expenses from AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Merck Sharp & Dohme, Novartis, and Pfizer; and participating in a data safety monitoring board or advisory board for AstraZeneca, Bayer, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Janssen, Merck Sharp & Dohme, Novartis, Pfizer, and Teva. Dr. Nadal reports receiving honoraria/consultancy fees/lectures from Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Merck Serono, Merck Sharp & Dohme, Pfizer, and Takeda; and research funding from Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., and Merck Serono. Dr. de Marinis reports receiving honoraria from F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb, AstraZeneca, and Merck. Dr. Arén Frontera reports receiving honoraria from Bristol-Myers Squibb Chile. Dr. Tan reports receiving honoraria/consultancy fees from AstraZeneca, Bayer, Boehringer Ingelheim, Celgene, Eli Lilly, Loxo Oncology, Merck, Novartis, Pfizer, Roche, and Takeda; receiving research grants from AstraZeneca, Bayer, GlaxoSmithKline, Novartis, and Pfizer; and receiving travel or accommodation expenses from Boehringer Ingelheim, Merck, Novartis, Pfizer, Roche, and Takeda. Dr. Lee reports receiving honoraria/consultancy fees from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, CJ Healthcare, Eli Lilly, Chong Kun Dang, Janssen, Merck, Merck Sharp & Dohme, Mundipharma, Novartis, Ono, Pfizer, Roche, Samyang Biopharm, STCube Pharmaceuticals, AbbVie, Takeda, Genexine, and Menarini. Dr. Kim reports receiving honoraria/consultancy fees from AstraZeneca, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Ono, and Takeda. Dr. Yan is an employee of F. Hoffmann-La Roche Ltd. Dr. Riehl, Dr. Schleifman, Dr. Paul, Dr. Mocci, Dr. Patel, Dr. Assaf, Dr. Shames, and Dr. Mathisen are employees of Genentech, Inc. Dr. Riehl, Dr. Schleifman, and Dr. Paul also report owning stocks in F. Hoffmann-La Roche Ltd. Dr. Assaf also reports receiving support for attending meetings and/or travel from and owning stock in Genentech, Inc. Dr. Gadgeel reports receiving honoraria/consultancy fees from Takeda, AstraZeneca, Bristol-Myers Squibb, Xcovery, Boehringer Ingelheim, AbbVie, Novocure, Pfizer, Janssen, Eli Lilly, Merck, Blueprint Medicines, and F. Hoffmann-La Roche Ltd./Genentech and participating on a data safety monitoring board or advisory board for AstraZeneca.",
                        "@xml:lang": "eng"
                    },
                    "grant": [
                        {
                            "grant-acronym": "Abbvie",
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "AbbVie"
                            },
                            "grant-agency-id": "100006483"
                        },
                        {
                            "grant-acronym": "BMS",
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Bristol-Myers Squibb"
                            },
                            "grant-agency-id": "100002491"
                        },
                        {
                            "grant-acronym": "BMS",
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Bristol-Myers Squibb"
                            },
                            "grant-agency-id": "100002491"
                        },
                        {
                            "grant-acronym": "BMS",
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Bristol-Myers Squibb"
                            },
                            "grant-agency-id": "100002491"
                        },
                        {
                            "grant-acronym": "BMS",
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Bristol-Myers Squibb"
                            },
                            "grant-agency-id": "100002491"
                        },
                        {
                            "grant-acronym": "BMS",
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Bristol-Myers Squibb"
                            },
                            "grant-agency-id": "100002491"
                        },
                        {
                            "grant-acronym": "BMS",
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Bristol-Myers Squibb"
                            },
                            "grant-agency-id": "100002491"
                        },
                        {
                            "grant-acronym": "MSD",
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "Merck Sharp and Dohme"
                            },
                            "grant-agency-id": "100009947"
                        },
                        {
                            "grant-acronym": "MSD",
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "Merck Sharp and Dohme"
                            },
                            "grant-agency-id": "100009947"
                        },
                        {
                            "grant-acronym": "MSD",
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "Merck Sharp and Dohme"
                            },
                            "grant-agency-id": "100009947"
                        },
                        {
                            "grant-acronym": "MSD",
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "Merck Sharp and Dohme"
                            },
                            "grant-agency-id": "100009947"
                        },
                        {
                            "grant-acronym": "MSD",
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "Merck Sharp and Dohme"
                            },
                            "grant-agency-id": "100009947"
                        },
                        {
                            "grant-acronym": "MSD",
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "Merck Sharp and Dohme"
                            },
                            "grant-agency-id": "100009947"
                        },
                        {
                            "grant-acronym": "Takeda",
                            "grant-agency": {
                                "@iso-code": "can",
                                "$": "Takeda Canada"
                            },
                            "grant-agency-id": "100016040"
                        },
                        {
                            "grant-acronym": "Takeda",
                            "grant-agency": {
                                "@iso-code": "can",
                                "$": "Takeda Canada"
                            },
                            "grant-agency-id": "100016040"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Amgen"
                            },
                            "grant-agency-id": "100002429"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Amgen"
                            },
                            "grant-agency-id": "100002429"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "gbr",
                                "$": "AstraZeneca"
                            },
                            "grant-agency-id": "100004325"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "deu",
                                "$": "Bayer"
                            },
                            "grant-agency-id": "100004326"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Clovis Oncology"
                            },
                            "grant-agency-id": "100014487"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Clovis Oncology"
                            },
                            "grant-agency-id": "100014487"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Genentech"
                            },
                            "grant-agency-id": "100004328"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Genentech"
                            },
                            "grant-agency-id": "100004328"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Illumina"
                            },
                            "grant-agency-id": "100010905"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Illumina"
                            },
                            "grant-agency-id": "100010905"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Imedex"
                            },
                            "grant-agency-id": "100006972"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Merck"
                            },
                            "grant-agency-id": "100004334"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Merck"
                            },
                            "grant-agency-id": "100004334"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Novartis"
                            },
                            "grant-agency-id": "100004336"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Novartis"
                            },
                            "grant-agency-id": "100004336"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Novartis"
                            },
                            "grant-agency-id": "100004336"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Pfizer"
                            },
                            "grant-agency-id": "100004319"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Pfizer"
                            },
                            "grant-agency-id": "100004319"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Pfizer"
                            },
                            "grant-agency-id": "100004319"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Pfizer"
                            },
                            "grant-agency-id": "100004319"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Pfizer"
                            },
                            "grant-agency-id": "100004319"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Regeneron Pharmaceuticals"
                            },
                            "grant-agency-id": "100009857"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "che",
                                "$": "Roche"
                            },
                            "grant-agency-id": "100004337"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Sanofi"
                            },
                            "grant-agency-id": "100004339"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Seattle Genetics"
                            },
                            "grant-agency-id": "100010293"
                        },
                        {
                            "grant-agency": {
                                "@iso-code": "usa",
                                "$": "Takeda Oncology"
                            },
                            "grant-agency-id": "100011957"
                        }
                    ]
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2022 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "MEDLINE",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "01",
                    "@timestamp": "BST 10:52:34",
                    "@year": "2022",
                    "@month": "07"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2014271114",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "635732979",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "935280875",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20210828187",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "34311110",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "20213184644",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20212894361",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "85113572829",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85113572829",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "635732979",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "78898199",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:pii": "S1556086421023212",
                    "ce:ern": "pii:S1556086421023212",
                    "ce:doi": "10.1016/j.jtho.2021.07.008"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "28",
                "reference": [
                    {
                        "ref-fulltext": "National Comprehensive Cancer Network. Non-small cell lung cancer, version 4.2021. https://www.nccn.org/professionals/physician_gls/default.aspx. (Accessed 5 May 2021)",
                        "@id": "1",
                        "ref-info": {
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.nccn.org/professionals/physician_gls/default.aspx",
                                "@type": "email"
                            }},
                            "ref-title": {"ref-titletext": "Non-small cell lung cancer, version 4.2021"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib1",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84871351824",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "(Accessed 5 May 2021)",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "National Comprehensive Cancer Network",
                                "ce:indexed-name": "National Comprehensive Cancer Network"
                            }}
                        },
                        "ce:source-text": "National Comprehensive Cancer Network. Non-small cell lung cancer, version 4.2021. https://www.nccn.org/professionals/physician_gls/default.aspx. Accessed XXX."
                    },
                    {
                        "ref-fulltext": "Lindeman, N.I., Cagle, P.T., Aisner, D.L., et al. Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. J Thorac Oncol 13 (2018), 323\u2013358.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib2",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85040769249",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "323",
                                    "@last": "358"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.I.",
                                        "@_fa": "true",
                                        "ce:surname": "Lindeman",
                                        "ce:indexed-name": "Lindeman N.I."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Cagle",
                                        "ce:indexed-name": "Cagle P.T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Aisner",
                                        "ce:indexed-name": "Aisner D.L."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Thorac Oncol"
                        },
                        "ce:source-text": "Lindeman NI, Cagle PT, Aisner DL, et al. Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology. J Thorac Oncol. 2018;13:323-358."
                    },
                    {
                        "ref-fulltext": "Planchard, D., Popat, S., Kerr, K., et al. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Updated September 2020. Ann Oncol 29:suppl 4 (2018), iv192\u2013iv237.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Updated September 2020"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib3",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85054351450",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "29"},
                                "pagerange": {
                                    "@first": "iv192",
                                    "@last": "iv237"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Planchard",
                                        "ce:indexed-name": "Planchard D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Popat",
                                        "ce:indexed-name": "Popat S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Kerr",
                                        "ce:indexed-name": "Kerr K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Planchard D, Popat S, Kerr K, et al. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Updated September 2020. Ann Oncol. 2018;29(suppl 4):iv192-iv237."
                    },
                    {
                        "ref-fulltext": "Lim, C., Tsao, M.S., Le, L.W., et al. Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer. Ann Oncol 26 (2015), 1415\u20131421.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib4",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84946737759",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "26"},
                                "pagerange": {
                                    "@first": "1415",
                                    "@last": "1421"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Lim",
                                        "ce:indexed-name": "Lim C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Tsao",
                                        "ce:indexed-name": "Tsao M.S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Le",
                                        "ce:indexed-name": "Le L.W."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Lim C, Tsao MS, Le LW, et al. Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer. Ann Oncol. 2015;26:1415-1421."
                    },
                    {
                        "ref-fulltext": "Mlika, M., Dziri, C., Zorgati, M.M., Ben Khelil, M., Mezni, F., Liquid biopsy as surrogate to tissue in lung cancer for molecular profiling: a meta-analysis. Curr Respir Med Rev 14 (2018), 48\u201360.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Liquid biopsy as surrogate to tissue in lung cancer for molecular profiling: a meta-analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib5",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85050361997",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "48",
                                    "@last": "60"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Mlika",
                                    "ce:indexed-name": "Mlika M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Dziri",
                                    "ce:indexed-name": "Dziri C."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Zorgati",
                                    "ce:indexed-name": "Zorgati M.M."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Ben Khelil",
                                    "ce:indexed-name": "Ben Khelil M."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Mezni",
                                    "ce:indexed-name": "Mezni F."
                                }
                            ]},
                            "ref-sourcetitle": "Curr Respir Med Rev"
                        },
                        "ce:source-text": "Mlika M, Dziri C, Zorgati MM, Ben Khelil M, Mezni F. Liquid biopsy as surrogate to tissue in lung cancer for molecular profiling: a meta-analysis. Curr Respir Med Rev. 2018;14:48-60."
                    },
                    {
                        "ref-fulltext": "Aggarwal, C., Thompson, J.C., Black, T.A., et al. Clinical implications of plasma-based genotyping with the delivery of personalized therapy in metastatic non-small cell lung cancer. JAMA Oncol 5 (2019), 173\u2013180.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Clinical implications of plasma-based genotyping with the delivery of personalized therapy in metastatic non-small cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib6",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85054958025",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "5"},
                                "pagerange": {
                                    "@first": "173",
                                    "@last": "180"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Aggarwal",
                                        "ce:indexed-name": "Aggarwal C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.C.",
                                        "@_fa": "true",
                                        "ce:surname": "Thompson",
                                        "ce:indexed-name": "Thompson J.C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Black",
                                        "ce:indexed-name": "Black T.A."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JAMA Oncol"
                        },
                        "ce:source-text": "Aggarwal C, Thompson JC, Black TA, et al. Clinical implications of plasma-based genotyping with the delivery of personalized therapy in metastatic non-small cell lung cancer. JAMA Oncol. 2019;5:173-180."
                    },
                    {
                        "ref-fulltext": "Chouaid, C., Dujon, C., Do, P., et al. Feasibility and clinical impact of re-biopsy in advanced non small-cell lung cancer: a prospective multicenter study in a real-world setting (GFPC study 12-01). Lung Cancer 86 (2014), 170\u2013173.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Feasibility and clinical impact of re-biopsy in advanced non small-cell lung cancer: a prospective multicenter study in a real-world setting (GFPC study 12-01)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib7",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84908407258",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "86"},
                                "pagerange": {
                                    "@first": "170",
                                    "@last": "173"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Chouaid",
                                        "ce:indexed-name": "Chouaid C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Dujon",
                                        "ce:indexed-name": "Dujon C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Do",
                                        "ce:indexed-name": "Do P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lung Cancer"
                        },
                        "ce:source-text": "Chouaid C, Dujon C, Do P, et al. Feasibility and clinical impact of re-biopsy in advanced non small-cell lung cancer: a prospective multicenter study in a real-world setting (GFPC study 12-01). Lung Cancer. 2014;86:170-173."
                    },
                    {
                        "ref-fulltext": "McCoach, C.E., Le, A.T., Gowan, K., et al. Resistance mechanisms to targeted therapies in ROS1(+) and ALK(+) non-small cell lung cancer. Clin Cancer Res 24 (2018), 3334\u20133347.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Resistance mechanisms to targeted therapies in ROS1(+) and ALK(+) non-small cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib8",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85050080102",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "24"},
                                "pagerange": {
                                    "@first": "3334",
                                    "@last": "3347"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.E.",
                                        "@_fa": "true",
                                        "ce:surname": "McCoach",
                                        "ce:indexed-name": "McCoach C.E."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Le",
                                        "ce:indexed-name": "Le A.T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Gowan",
                                        "ce:indexed-name": "Gowan K."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Cancer Res"
                        },
                        "ce:source-text": "McCoach CE, Le AT, Gowan K, et al. Resistance mechanisms to targeted therapies in ROS1(+) and ALK(+) non-small cell lung cancer. Clin Cancer Res. 2018;24:3334-3347."
                    },
                    {
                        "ref-fulltext": "Schrock, A.B., Welsh, A., Chung, J.H., et al. Hybrid capture-based genomic profiling of circulating tumor DNA from patients with advanced non-small cell lung cancer. J Thorac Oncol 14 (2019), 255\u2013264.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Hybrid capture-based genomic profiling of circulating tumor DNA from patients with advanced non-small cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib9",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85057630908",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "255",
                                    "@last": "264"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.B.",
                                        "@_fa": "true",
                                        "ce:surname": "Schrock",
                                        "ce:indexed-name": "Schrock A.B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Welsh",
                                        "ce:indexed-name": "Welsh A."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Chung",
                                        "ce:indexed-name": "Chung J.H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Thorac Oncol"
                        },
                        "ce:source-text": "Schrock AB, Welsh A, Chung JH, et al. Hybrid capture-based genomic profiling of circulating tumor DNA from patients with advanced non-small cell lung cancer. J Thorac Oncol. 2019;14:255-264."
                    },
                    {
                        "ref-fulltext": "Diaz, L.A. Jr., Bardelli, A., Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol 32 (2014), 579\u2013586.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Liquid biopsies: genotyping circulating tumor DNA"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib10",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84898542288",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "32"},
                                "pagerange": {
                                    "@first": "579",
                                    "@last": "586"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Diaz",
                                    "ce:suffix": "Jr.",
                                    "ce:indexed-name": "Diaz L.A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Bardelli",
                                    "ce:indexed-name": "Bardelli A."
                                }
                            ]},
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Diaz LA Jr, Bardelli A. Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol. 2014;32:579-586."
                    },
                    {
                        "ref-fulltext": "Mok, T., Wu, Y.L., Lee, J.S., et al. Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC patients treated with first-line intercalated erlotinib and chemotherapy. Clin Cancer Res 21 (2015), 3196\u20133203.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC patients treated with first-line intercalated erlotinib and chemotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib11",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "84938399710",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "21"},
                                "pagerange": {
                                    "@first": "3196",
                                    "@last": "3203"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Mok",
                                        "ce:indexed-name": "Mok T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y.L.",
                                        "@_fa": "true",
                                        "ce:surname": "Wu",
                                        "ce:indexed-name": "Wu Y.L."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.S.",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee J.S."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Cancer Res"
                        },
                        "ce:source-text": "Mok T, Wu YL, Lee JS, et al. Detection and dynamic changes of EGFR mutations from circulating tumor DNA as a predictor of survival outcomes in NSCLC patients treated with first-line intercalated erlotinib and chemotherapy. Clin Cancer Res. 2015;21:3196-3203."
                    },
                    {
                        "ref-fulltext": "Gandara, D.R., Paul, S.M., Kowanetz, M., et al. Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab. Nat Med 24 (2018), 1441\u20131448.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib12",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85052511307",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "24"},
                                "pagerange": {
                                    "@first": "1441",
                                    "@last": "1448"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Gandara",
                                        "ce:indexed-name": "Gandara D.R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Paul",
                                        "ce:indexed-name": "Paul S.M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Kowanetz",
                                        "ce:indexed-name": "Kowanetz M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat Med"
                        },
                        "ce:source-text": "Gandara DR, Paul SM, Kowanetz M, et al. Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab. Nat Med. 2018;24:1441-1448."
                    },
                    {
                        "ref-fulltext": "Clark, T.A., Chung, J.H., Kennedy, M., et al. Analytical validation of a hybrid capture-based next-generation sequencing clinical assay for genomic profiling of cell-free circulating tumor DNA. J Mol Diagn 20 (2018), 686\u2013702.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Analytical validation of a hybrid capture-based next-generation sequencing clinical assay for genomic profiling of cell-free circulating tumor DNA"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib13",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85051635969",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "20"},
                                "pagerange": {
                                    "@first": "686",
                                    "@last": "702"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.A.",
                                        "@_fa": "true",
                                        "ce:surname": "Clark",
                                        "ce:indexed-name": "Clark T.A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.H.",
                                        "@_fa": "true",
                                        "ce:surname": "Chung",
                                        "ce:indexed-name": "Chung J.H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Kennedy",
                                        "ce:indexed-name": "Kennedy M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Mol Diagn"
                        },
                        "ce:source-text": "Clark TA, Chung JH, Kennedy M, et al. Analytical validation of a hybrid capture-based next-generation sequencing clinical assay for genomic profiling of cell-free circulating tumor DNA. J Mol Diagn. 2018;20:686-702."
                    },
                    {
                        "ref-fulltext": "Woodhouse, R., Li, M., Hughes, J., et al. Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin. PLoS One, 15, 2020, e0237802.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib14",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "e0237802",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "85091808500",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "15"}},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Woodhouse",
                                        "ce:indexed-name": "Woodhouse R."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li M."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Hughes",
                                        "ce:indexed-name": "Hughes J."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS One"
                        },
                        "ce:source-text": "Woodhouse R, Li M, Hughes J, et al. Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin. PLoS One. 2020;15:e0237802."
                    },
                    {
                        "ref-fulltext": "Du, X., Shao, Y., Qin, H.F., Tai, Y.H., Gao, H.J., ALK-rearrangement in non-small-cell lung cancer (NSCLC). Thorac Cancer 9 (2018), 423\u2013430.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "ALK-rearrangement in non-small-cell lung cancer (NSCLC)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib15",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85042565120",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {
                                    "@first": "423",
                                    "@last": "430"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "X.",
                                    "@_fa": "true",
                                    "ce:surname": "Du",
                                    "ce:indexed-name": "Du X."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Shao",
                                    "ce:indexed-name": "Shao Y."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "H.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Qin",
                                    "ce:indexed-name": "Qin H.F."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "Y.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Tai",
                                    "ce:indexed-name": "Tai Y.H."
                                },
                                {
                                    "@seq": "5",
                                    "ce:initials": "H.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Gao",
                                    "ce:indexed-name": "Gao H.J."
                                }
                            ]},
                            "ref-sourcetitle": "Thorac Cancer"
                        },
                        "ce:source-text": "Du X, Shao Y, Qin HF, Tai YH, Gao HJ. ALK-rearrangement in non-small-cell lung cancer (NSCLC). Thorac Cancer. 2018;9:423-430."
                    },
                    {
                        "ref-fulltext": "Peters, S., Camidge, D.R., Shaw, A.T., et al. Alectinib versus crizotinib in untreated ALK-positive non-small-cell lung cancer. N Engl J Med 377 (2017), 829\u2013838.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Alectinib versus crizotinib in untreated ALK-positive non-small-cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib16",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85027524894",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "377"},
                                "pagerange": {
                                    "@first": "829",
                                    "@last": "838"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Peters",
                                        "ce:indexed-name": "Peters S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Camidge",
                                        "ce:indexed-name": "Camidge D.R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Shaw",
                                        "ce:indexed-name": "Shaw A.T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Peters S, Camidge DR, Shaw AT, et al. Alectinib versus crizotinib in untreated ALK-positive non-small-cell lung cancer. N Engl J Med. 2017;377:829-838."
                    },
                    {
                        "ref-fulltext": "Mok, T.S.K., Shaw, A.T., Camidge, R.D., et al. Final PFS, updated OS and safety data from the randomised, phase III ALEX study of alectinib (ALC) versus crizotinib (CRZ) in untreated advanced ALK+ NSCLC. 1484PD (updated data presented). Ann Oncol, 30(suppl 5), 2019, V607.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Final PFS, updated OS and safety data from the randomised, phase III ALEX study of alectinib (ALC) versus crizotinib (CRZ) in untreated advanced ALK+ NSCLC. 1484PD (updated data presented)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib17",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85078240833",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "30"},
                                "pagerange": {"@first": "V607"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.S.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Mok",
                                        "ce:indexed-name": "Mok T.S.K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A.T.",
                                        "@_fa": "true",
                                        "ce:surname": "Shaw",
                                        "ce:indexed-name": "Shaw A.T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Camidge",
                                        "ce:indexed-name": "Camidge R.D."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Mok TSK, Shaw AT, Camidge RD, et al. Final PFS, updated OS and safety data from the randomised, phase III ALEX study of alectinib (ALC) versus crizotinib (CRZ) in untreated advanced ALK+ NSCLC. Ann Oncol. 2019;30(suppl 5):v602-v660."
                    },
                    {
                        "ref-fulltext": "Leighl, N.B., Page, R.D., Raymond, V.M., et al. Clinical utility of comprehensive cell-free DNA analysis to identify genomic biomarkers in patients with newly diagnosed metastatic non-small cell lung cancer. Clin Cancer Res 25 (2019), 4691\u20134700.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Clinical utility of comprehensive cell-free DNA analysis to identify genomic biomarkers in patients with newly diagnosed metastatic non-small cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib18",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85069756770",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "25"},
                                "pagerange": {
                                    "@first": "4691",
                                    "@last": "4700"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N.B.",
                                        "@_fa": "true",
                                        "ce:surname": "Leighl",
                                        "ce:indexed-name": "Leighl N.B."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R.D.",
                                        "@_fa": "true",
                                        "ce:surname": "Page",
                                        "ce:indexed-name": "Page R.D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Raymond",
                                        "ce:indexed-name": "Raymond V.M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Cancer Res"
                        },
                        "ce:source-text": "Leighl NB, Page RD, Raymond VM, et al. Clinical utility of comprehensive cell-free DNA analysis to identify genomic biomarkers in patients with newly diagnosed metastatic non-small cell lung cancer. Clin Cancer Res. 2019;25:4691-4700."
                    },
                    {
                        "ref-fulltext": "Petrelli, F., Lazzari, C., Ardito, R., et al. Efficacy of ALK inhibitors on NSCLC brain metastases: a systematic review and pooled analysis of 21 studies. PLoS One, 13, 2018, e0201425.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Efficacy of ALK inhibitors on NSCLC brain metastases: a systematic review and pooled analysis of 21 studies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib19",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "e0201425",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "85051692246",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "13"}},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F.",
                                        "@_fa": "true",
                                        "ce:surname": "Petrelli",
                                        "ce:indexed-name": "Petrelli F."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Lazzari",
                                        "ce:indexed-name": "Lazzari C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Ardito",
                                        "ce:indexed-name": "Ardito R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS One"
                        },
                        "ce:source-text": "Petrelli F, Lazzari C, Ardito R, et al. Efficacy of ALK inhibitors on NSCLC brain metastases: a systematic review and pooled analysis of 21 studies. PLoS One. 2018;13:e0201425."
                    },
                    {
                        "ref-fulltext": "Mok, T., Camidge, D.R., Gadgeel, S.M., et al. Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study. Ann Oncol 31 (2020), 1056\u20131064.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib20",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85087025913",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "1056",
                                    "@last": "1064"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Mok",
                                        "ce:indexed-name": "Mok T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Camidge",
                                        "ce:indexed-name": "Camidge D.R."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.M.",
                                        "@_fa": "true",
                                        "ce:surname": "Gadgeel",
                                        "ce:indexed-name": "Gadgeel S.M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Mok T, Camidge DR, Gadgeel SM, et al. Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study. Ann Oncol. 2020;31:1056-1064."
                    },
                    {
                        "ref-fulltext": "Gadgeel, S., Peters, S., Mok, T., et al. Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study. Ann Oncol 29 (2018), 2214\u20132222.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib21",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85058604290",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "29"},
                                "pagerange": {
                                    "@first": "2214",
                                    "@last": "2222"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Gadgeel",
                                        "ce:indexed-name": "Gadgeel S."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Peters",
                                        "ce:indexed-name": "Peters S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Mok",
                                        "ce:indexed-name": "Mok T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Gadgeel S, Peters S, Mok T, et al. Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study. Ann Oncol. 2018;29:2214-2222."
                    },
                    {
                        "ref-fulltext": "Nakagawa, K., Hida, T., Nokihara, H., et al. Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer. Lung Cancer 139 (2020), 195\u2013199.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib22",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85077476741",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "139"},
                                "pagerange": {
                                    "@first": "195",
                                    "@last": "199"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K.",
                                        "@_fa": "true",
                                        "ce:surname": "Nakagawa",
                                        "ce:indexed-name": "Nakagawa K."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Hida",
                                        "ce:indexed-name": "Hida T."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Nokihara",
                                        "ce:indexed-name": "Nokihara H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lung Cancer"
                        },
                        "ce:source-text": "Nakagawa K, Hida T, Nokihara H, et al. Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer. Lung Cancer. 2020;139:195-199."
                    },
                    {
                        "ref-fulltext": "Zhou, C., Kim, S.W., Reungwetwattana, T., et al. Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study. Lancet Respir Med 7 (2019), 437\u2013446.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib23",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85064705621",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "437",
                                    "@last": "446"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Zhou",
                                        "ce:indexed-name": "Zhou C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Kim",
                                        "ce:indexed-name": "Kim S.W."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Reungwetwattana",
                                        "ce:indexed-name": "Reungwetwattana T."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Respir Med"
                        },
                        "ce:source-text": "Zhou C, Kim SW, Reungwetwattana T, et al. Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study. Lancet Respir Med. 2019;7:437-446."
                    },
                    {
                        "ref-fulltext": "Akhoundova, D., Mosquera Martinez, J., Musmann, L.E., et al. The role of the liquid biopsy in decision-making for patients with non-small cell lung cancer. J Clin Med, 9, 2020, 3674.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "The role of the liquid biopsy in decision-making for patients with non-small cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib24",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85100805152",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {"@first": "3674"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Akhoundova",
                                        "ce:indexed-name": "Akhoundova D."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Mosquera Martinez",
                                        "ce:indexed-name": "Mosquera Martinez J."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "L.E.",
                                        "@_fa": "true",
                                        "ce:surname": "Musmann",
                                        "ce:indexed-name": "Musmann L.E."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Med"
                        },
                        "ce:source-text": "Akhoundova D, Mosquera Martinez J, Musmann LE, et al. The role of the liquid biopsy in decision-making for patients with non-small cell lung cancer. J Clin Med. 2020;9:3674."
                    },
                    {
                        "ref-fulltext": "Mok, T., Peters, S., Camidge, D.R., et al. Outcomes according to ALK status determined by central immunohistochemistry or fluorescence in situ hybridization in patients with ALK-positive NSCLC enrolled in the phase 3 ALEX study. J Thor Oncol 16 (2021), 259\u2013268.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2021"},
                            "ref-title": {"ref-titletext": "Outcomes according to ALK status determined by central immunohistochemistry or fluorescence in situ hybridization in patients with ALK-positive NSCLC enrolled in the phase 3 ALEX study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib25",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85099513249",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "259",
                                    "@last": "268"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T.",
                                        "@_fa": "true",
                                        "ce:surname": "Mok",
                                        "ce:indexed-name": "Mok T."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Peters",
                                        "ce:indexed-name": "Peters S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.R.",
                                        "@_fa": "true",
                                        "ce:surname": "Camidge",
                                        "ce:indexed-name": "Camidge D.R."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Thor Oncol"
                        },
                        "ce:source-text": "Mok T, Peters S, Camidge DR, et al. Outcomes according to ALK status determined by central immunohistochemistry or fluorescence in situ hybridization in patients with ALK-positive NSCLC enrolled in the phase 3 ALEX study. J Thor Oncol. 2021;16:259-268."
                    },
                    {
                        "ref-fulltext": "Vollbrecht, C., Lenze, D., Hummel, M., et al. RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC/FISH discordance. BMC Cancer, 18, 2018, 1158.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC/FISH discordance"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib26",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85057090823",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {"@first": "1158"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Vollbrecht",
                                        "ce:indexed-name": "Vollbrecht C."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Lenze",
                                        "ce:indexed-name": "Lenze D."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Hummel",
                                        "ce:indexed-name": "Hummel M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "BMC Cancer"
                        },
                        "ce:source-text": "Vollbrecht C, Lenze D, Hummel M, et al. RNA-based analysis of ALK fusions in non-small cell lung cancer cases showing IHC/FISH discordance. BMC Cancer. 2018;18:1158."
                    },
                    {
                        "ref-fulltext": "Kron, A., Alidousty, C., Scheffler, M., et al. Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer. Ann Oncol 29 (2018), 2068\u20132075.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib27",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85055955285",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "29"},
                                "pagerange": {
                                    "@first": "2068",
                                    "@last": "2075"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Kron",
                                        "ce:indexed-name": "Kron A."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Alidousty",
                                        "ce:indexed-name": "Alidousty C."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Scheffler",
                                        "ce:indexed-name": "Scheffler M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Kron A, Alidousty C, Scheffler M, et al. Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer. Ann Oncol. 2018;29:2068-2075."
                    },
                    {
                        "ref-fulltext": "Wang, W.X., Xu, C.W., Chen, Y.P., et al. TP53 mutations predict for poor survival in ALK rearrangement lung adenocarcinoma patients treated with crizotinib. J Thorac Dis 10 (2018), 2991\u20132998.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "TP53 mutations predict for poor survival in ALK rearrangement lung adenocarcinoma patients treated with crizotinib"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "bib28",
                                    "@idtype": "FRAGMENTID"
                                },
                                {
                                    "$": "85048008503",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {
                                    "@first": "2991",
                                    "@last": "2998"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W.X.",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang W.X."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C.W.",
                                        "@_fa": "true",
                                        "ce:surname": "Xu",
                                        "ce:indexed-name": "Xu C.W."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Y.P.",
                                        "@_fa": "true",
                                        "ce:surname": "Chen",
                                        "ce:indexed-name": "Chen Y.P."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Thorac Dis"
                        },
                        "ce:source-text": "Wang WX, Xu CW, Chen YP, et al. TP53 mutations predict for poor survival in ALK rearrangement lung adenocarcinoma patients treated with crizotinib. J Thorac Dis. 2018;10:2991-2998."
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Seoul",
            "@id": "60115402",
            "affilname": "Yonsei Cancer Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60115402",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Goyang",
            "@id": "60068716",
            "affilname": "National Cancer Center, Gyeonggi",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60068716",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Singapore City",
            "@id": "60031809",
            "affilname": "National Cancer Centre, Singapore",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031809",
            "affiliation-country": "Singapore"
        },
        {
            "affiliation-city": "Detroit",
            "@id": "60030704",
            "affilname": "Henry Ford Health System",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030704",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Milan",
            "@id": "60030442",
            "affilname": "Istituto Europeo di Oncologia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030442",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60027817",
            "affilname": "Princess Margaret Cancer Centre",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027817",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "San Francisco",
            "@id": "60026209",
            "affilname": "Genentech, Inc",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026209",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Lausanne",
            "@id": "60023561",
            "affilname": "Centre Hospitalier Universitaire Vaudois",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023561",
            "affiliation-country": "Switzerland"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Lyon",
            "@id": "60018084",
            "affilname": "Le Centre Régional de Lutte Contre le Cancer Léon Bérard",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018084",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Hospitalet de Llobregat",
            "@id": "60015633",
            "affilname": "Institute Catala Oncologia",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015633",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Gdańsk",
            "@id": "60012383",
            "affilname": "Gdanski Uniwersytet Medyczny",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012383",
            "affiliation-country": "Poland"
        },
        {
            "affiliation-city": "Sao Paulo",
            "@id": "60008088",
            "affilname": "Universidade de São Paulo",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008088",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Seoul",
            "@id": "60006240",
            "affilname": "University of Ulsan College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006240",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Hong Kong",
            "@id": "60002798",
            "affilname": "Chinese University of Hong Kong",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002798",
            "affiliation-country": "Hong Kong"
        },
        {
            "affiliation-city": "Mexico City",
            "@id": "124797096",
            "affilname": "Health Pharma Professional Research",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/124797096",
            "affiliation-country": "Mexico"
        },
        {
            "affiliation-city": "Santiago",
            "@id": "121490051",
            "affilname": "Centro de Investigación Clínica Bradford Hill",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/121490051",
            "affiliation-country": "Chile"
        },
        {
            "affiliation-city": "Mississauga",
            "@id": "100363548",
            "affilname": "Hoffmann-La Roche Ltd",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100363548",
            "affiliation-country": "Canada"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85113572829",
        "dc:description": "Introduction: The Blood First Assay Screening Trial is an ongoing open-label, multicohort study, prospectively evaluating the relationship between blood-based next-generation sequencing (NGS) detection of actionable genetic alterations and activity of targeted therapies or immunotherapy in treatment-naive advanced or metastatic NSCLC. We present data from the ALK-positive cohort. Methods: Patients aged more than or equal to 18 years with stage IIIB or IV NSCLC and ALK rearrangements detected by blood-based NGS using hybrid capture technology (FoundationACT) received alectinib 600 mg twice daily. Asymptomatic or treated central nervous system (CNS) metastases were permitted. Primary end point was investigator-assessed objective response rate (ORR; Response Evaluation Criteria in Solid Tumors version 1.1). Secondary end points were independent review facility-assessed ORR, duration of response, progression-free survival (PFS), overall survival, and safety. Exploratory end points were investigator-assessed ORR in patients with baseline CNS metastases and relationship between circulating biomarkers and response. Results: In total, 2219 patients were screened and blood-based NGS yielded results in 98.6% of the cases. Of these, 119 patients (5.4%) had ALK-positive disease; 87 were enrolled and received alectinib. Median follow-up was 12.6 months (range: 2.6\u201318.7). Confirmed ORR was 87.4% (95% confidence interval [CI]: 78.5\u201393.5) by investigator and 92.0% (95% CI: 84.1\u201396.7) by independent review facility. Investigator-confirmed 12-month duration of response was 75.9% (95% CI: 63.6\u201388.2). In 35 patients (40%) with baseline CNS disease, investigator-assessed ORR was 91.4% (95% CI: 76.9\u201398.2). Median PFS was not reached; 12-month investigator-assessed PFS was 78.4% (95% CI: 69.1\u201387.7). Safety data were consistent with the known tolerability profile of alectinib. Conclusions: These results reveal the clinical application of blood-based NGS as a method to inform clinical decision-making in ALK-positive NSCLC.",
        "pubmed-id": "34311110",
        "prism:coverDate": "2021-12-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85113572829",
        "dc:creator": {"author": [{
            "ce:given-name": "Rafal",
            "preferred-name": {
                "ce:given-name": "Rafal",
                "ce:initials": "R.",
                "ce:surname": "Dziadziuszko",
                "ce:indexed-name": "Dziadziuszko R."
            },
            "@seq": "1",
            "ce:initials": "R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60012383",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012383"
            },
            "ce:degrees": "MD",
            "ce:surname": "Dziadziuszko",
            "@auid": "55888221300",
            "author-url": "https://api.elsevier.com/content/author/author_id/55888221300",
            "ce:indexed-name": "Dziadziuszko R."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85113572829"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85113572829&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85113572829&origin=inward"
            }
        ],
        "source-id": "6400153137",
        "pii": "S1556086421023212",
        "citedby-count": "19",
        "prism:volume": "16",
        "subtype": "cp",
        "dc:title": "Blood First Assay Screening Trial (BFAST) in Treatment-Naive Advanced or Metastatic NSCLC: Initial Results of the Phase 2 ALK-Positive Cohort",
        "openaccess": "1",
        "prism:issn": "15561380 15560864",
        "publishercopyright": "© 2021 International Association for the Study of Lung Cancer",
        "prism:issueIdentifier": "12",
        "subtypeDescription": "Conference Paper",
        "prism:publicationName": "Journal of Thoracic Oncology",
        "prism:pageRange": "2040-2050",
        "prism:endingPage": "2050",
        "openaccessFlag": "true",
        "prism:doi": "10.1016/j.jtho.2021.07.008",
        "prism:startingPage": "2040",
        "dc:identifier": "SCOPUS_ID:85113572829",
        "dc:publisher": "Elsevier Inc."
    },
    "idxterms": {"mainterm": [
        {
            "$": "Anaplastic Lymphoma Kinase",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Carcinoma, Non-Small-Cell Lung",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Cohort Studies",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Crizotinib",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Lung Neoplasms",
            "@weight": "a",
            "@candidate": "n"
        },
        {
            "$": "Protein Kinase Inhibitors",
            "@weight": "b",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "Alectinib"
        },
        {
            "@_fa": "true",
            "$": "ALK-positive"
        },
        {
            "@_fa": "true",
            "$": "Blood-based assay"
        },
        {
            "@_fa": "true",
            "$": "Next-generation sequencing"
        },
        {
            "@_fa": "true",
            "$": "NSCLC"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Pulmonary and Respiratory Medicine",
            "@code": "2740",
            "@abbrev": "MEDI"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Rafal",
            "preferred-name": {
                "ce:given-name": "Rafal",
                "ce:initials": "R.",
                "ce:surname": "Dziadziuszko",
                "ce:indexed-name": "Dziadziuszko R."
            },
            "@seq": "1",
            "ce:initials": "R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60012383",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012383"
            },
            "ce:degrees": "MD",
            "ce:surname": "Dziadziuszko",
            "@auid": "55888221300",
            "author-url": "https://api.elsevier.com/content/author/author_id/55888221300",
            "ce:indexed-name": "Dziadziuszko R."
        },
        {
            "ce:given-name": "Tony",
            "preferred-name": {
                "ce:given-name": "Tony",
                "ce:initials": "T.",
                "ce:surname": "Mok",
                "ce:indexed-name": "Mok T."
            },
            "@seq": "2",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60002798",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002798"
            },
            "ce:degrees": "MD",
            "ce:surname": "Mok",
            "@auid": "7006561460",
            "author-url": "https://api.elsevier.com/content/author/author_id/7006561460",
            "ce:indexed-name": "Mok T."
        },
        {
            "ce:given-name": "Solange",
            "preferred-name": {
                "ce:given-name": "Solange",
                "ce:initials": "S.",
                "ce:surname": "Peters",
                "ce:indexed-name": "Peters S."
            },
            "@seq": "3",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60023561",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023561"
            },
            "ce:degrees": "MD, PhD",
            "ce:surname": "Peters",
            "@auid": "57218315686",
            "author-url": "https://api.elsevier.com/content/author/author_id/57218315686",
            "ce:indexed-name": "Peters S."
        },
        {
            "ce:given-name": "Ji-Youn",
            "preferred-name": {
                "ce:given-name": "Ji Youn",
                "ce:initials": "J.Y.",
                "ce:surname": "Han",
                "ce:indexed-name": "Han J.Y."
            },
            "@seq": "4",
            "ce:initials": "J.-Y.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60068716",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60068716"
            },
            "ce:degrees": "MD, PhD",
            "ce:surname": "Han",
            "@auid": "18042023400",
            "author-url": "https://api.elsevier.com/content/author/author_id/18042023400",
            "ce:indexed-name": "Han J.-Y."
        },
        {
            "ce:given-name": "Jorge",
            "preferred-name": {
                "ce:given-name": "Jorge",
                "ce:initials": "J.",
                "ce:surname": "Alatorre-Alexander",
                "ce:indexed-name": "Alatorre-Alexander J."
            },
            "@seq": "5",
            "ce:initials": "J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "124797096",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/124797096"
            },
            "ce:degrees": "MD",
            "ce:surname": "Alatorre-Alexander",
            "@auid": "55736184300",
            "author-url": "https://api.elsevier.com/content/author/author_id/55736184300",
            "ce:indexed-name": "Alatorre-Alexander J."
        },
        {
            "ce:given-name": "Natasha",
            "preferred-name": {
                "ce:given-name": "Natasha",
                "ce:initials": "N.",
                "ce:surname": "Leighl",
                "ce:indexed-name": "Leighl N."
            },
            "@seq": "6",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60027817",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027817"
            },
            "ce:degrees": "MD",
            "ce:surname": "Leighl",
            "@auid": "6602944827",
            "author-url": "https://api.elsevier.com/content/author/author_id/6602944827",
            "ce:indexed-name": "Leighl N."
        },
        {
            "ce:given-name": "Virote",
            "preferred-name": {
                "ce:given-name": "Virote",
                "ce:initials": "V.",
                "ce:surname": "Sriuranpong",
                "ce:indexed-name": "Sriuranpong V."
            },
            "@seq": "7",
            "ce:initials": "V.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60022183",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
            },
            "ce:degrees": "MD",
            "ce:surname": "Sriuranpong",
            "@auid": "6603599644",
            "author-url": "https://api.elsevier.com/content/author/author_id/6603599644",
            "ce:indexed-name": "Sriuranpong V."
        },
        {
            "ce:given-name": "Maurice",
            "preferred-name": {
                "ce:given-name": "Maurice",
                "ce:initials": "M.",
                "ce:surname": "Pérol",
                "ce:indexed-name": "Pérol M."
            },
            "@seq": "8",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60018084",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018084"
            },
            "ce:degrees": "MD",
            "ce:surname": "Pérol",
            "@auid": "7006708830",
            "author-url": "https://api.elsevier.com/content/author/author_id/7006708830",
            "ce:indexed-name": "Perol M."
        },
        {
            "ce:given-name": "Gilberto",
            "preferred-name": {
                "ce:given-name": "Gilberto",
                "ce:initials": "G.",
                "ce:surname": "de Castro Junior",
                "ce:indexed-name": "de Castro Junior G."
            },
            "@seq": "9",
            "ce:initials": "G.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60008088",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60008088"
            },
            "ce:degrees": "MD, PhD",
            "ce:surname": "de Castro Junior",
            "@auid": "57211774389",
            "author-url": "https://api.elsevier.com/content/author/author_id/57211774389",
            "ce:indexed-name": "de Castro Junior G."
        },
        {
            "ce:given-name": "Ernest",
            "preferred-name": {
                "ce:given-name": "Ernest",
                "ce:initials": "E.",
                "ce:surname": "Nadal",
                "ce:indexed-name": "Nadal E."
            },
            "@seq": "10",
            "ce:initials": "E.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60015633",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015633"
            },
            "ce:degrees": "MD",
            "ce:surname": "Nadal",
            "@auid": "36619073100",
            "author-url": "https://api.elsevier.com/content/author/author_id/36619073100",
            "ce:indexed-name": "Nadal E."
        },
        {
            "ce:given-name": "Filippo",
            "preferred-name": {
                "ce:given-name": "Filippo",
                "ce:initials": "F.",
                "ce:surname": "de Marinis",
                "ce:indexed-name": "de Marinis F."
            },
            "@seq": "11",
            "ce:initials": "F.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60030442",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030442"
            },
            "ce:degrees": "MD",
            "ce:surname": "de Marinis",
            "@auid": "56273853600",
            "author-url": "https://api.elsevier.com/content/author/author_id/56273853600",
            "ce:indexed-name": "de Marinis F."
        },
        {
            "ce:given-name": "Osvaldo Arén",
            "preferred-name": {
                "ce:given-name": "Osvaldo Arén",
                "ce:initials": "O.A.",
                "ce:surname": "Frontera",
                "ce:indexed-name": "Frontera O.A."
            },
            "@seq": "12",
            "ce:initials": "O.A.",
            "@_fa": "true",
            "affiliation": {
                "@id": "121490051",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/121490051"
            },
            "ce:degrees": "MD",
            "ce:surname": "Frontera",
            "@auid": "56716391100",
            "author-url": "https://api.elsevier.com/content/author/author_id/56716391100",
            "ce:indexed-name": "Frontera O.A."
        },
        {
            "ce:given-name": "Daniel S.W.",
            "preferred-name": {
                "ce:given-name": "Daniel S.W.",
                "ce:initials": "D.S.W.",
                "ce:surname": "Tan",
                "ce:indexed-name": "Tan D.S.W."
            },
            "@seq": "13",
            "ce:initials": "D.S.W.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60031809",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031809"
            },
            "ce:degrees": "MD",
            "ce:surname": "Tan",
            "@auid": "25931213800",
            "author-url": "https://api.elsevier.com/content/author/author_id/25931213800",
            "ce:indexed-name": "Tan D.S.W."
        },
        {
            "ce:given-name": "Dae Ho",
            "preferred-name": {
                "ce:given-name": "Dae Ho",
                "ce:initials": "D.H.",
                "ce:surname": "Lee",
                "ce:indexed-name": "Lee D.H."
            },
            "@seq": "14",
            "ce:initials": "D.H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60006240",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006240"
            },
            "ce:degrees": "MD",
            "ce:surname": "Lee",
            "@auid": "16401931900",
            "author-url": "https://api.elsevier.com/content/author/author_id/16401931900",
            "ce:indexed-name": "Lee D.H."
        },
        {
            "ce:given-name": "Hye Ryun",
            "preferred-name": {
                "ce:given-name": "Hye Ryun",
                "ce:initials": "H.R.",
                "ce:surname": "Kim",
                "ce:indexed-name": "Kim H.R."
            },
            "@seq": "15",
            "ce:initials": "H.R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60115402",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60115402"
            },
            "ce:degrees": "MD, PhD",
            "ce:surname": "Kim",
            "@auid": "8583782700",
            "author-url": "https://api.elsevier.com/content/author/author_id/8583782700",
            "ce:indexed-name": "Kim H.R."
        },
        {
            "ce:given-name": "Mark",
            "preferred-name": {
                "ce:given-name": "Mark",
                "ce:initials": "M.",
                "ce:surname": "Yan",
                "ce:indexed-name": "Yan M."
            },
            "@seq": "16",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "100363548",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100363548"
            },
            "ce:degrees": "PhD",
            "ce:surname": "Yan",
            "@auid": "57468482900",
            "author-url": "https://api.elsevier.com/content/author/author_id/57468482900",
            "ce:indexed-name": "Yan M."
        },
        {
            "ce:given-name": "Todd",
            "preferred-name": {
                "ce:given-name": "Todd",
                "ce:initials": "T.",
                "ce:surname": "Riehl",
                "ce:indexed-name": "Riehl T."
            },
            "@seq": "17",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60026209",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026209"
            },
            "ce:degrees": "PharmD",
            "ce:surname": "Riehl",
            "@auid": "57191887645",
            "author-url": "https://api.elsevier.com/content/author/author_id/57191887645",
            "ce:indexed-name": "Riehl T."
        },
        {
            "ce:given-name": "Erica",
            "preferred-name": {
                "ce:given-name": "Erica",
                "ce:initials": "E.",
                "ce:surname": "Schleifman",
                "ce:indexed-name": "Schleifman E."
            },
            "@seq": "18",
            "ce:initials": "E.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60026209",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026209"
            },
            "ce:degrees": "PhD",
            "ce:surname": "Schleifman",
            "@auid": "16680398700",
            "author-url": "https://api.elsevier.com/content/author/author_id/16680398700",
            "ce:indexed-name": "Schleifman E."
        },
        {
            "ce:given-name": "Sarah M.",
            "preferred-name": {
                "ce:given-name": "Sarah M.",
                "ce:initials": "S.M.",
                "ce:surname": "Paul",
                "ce:indexed-name": "Paul S.M."
            },
            "@seq": "19",
            "ce:initials": "S.M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60026209",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026209"
            },
            "ce:degrees": "PhD",
            "ce:surname": "Paul",
            "@auid": "57203640779",
            "author-url": "https://api.elsevier.com/content/author/author_id/57203640779",
            "ce:indexed-name": "Paul S.M."
        },
        {
            "ce:given-name": "Simonetta",
            "preferred-name": {
                "ce:given-name": "Simonetta",
                "ce:initials": "S.",
                "ce:surname": "Mocci",
                "ce:indexed-name": "Mocci S."
            },
            "@seq": "20",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60026209",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026209"
            },
            "ce:degrees": "MD, PhD",
            "ce:surname": "Mocci",
            "@auid": "56462674500",
            "author-url": "https://api.elsevier.com/content/author/author_id/56462674500",
            "ce:indexed-name": "Mocci S."
        },
        {
            "ce:given-name": "Rajesh",
            "preferred-name": {
                "ce:given-name": "Rajesh",
                "ce:initials": "R.",
                "ce:surname": "Patel",
                "ce:indexed-name": "Patel R."
            },
            "@seq": "21",
            "ce:initials": "R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60026209",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026209"
            },
            "ce:degrees": "PhD",
            "ce:surname": "Patel",
            "@auid": "55472426800",
            "author-url": "https://api.elsevier.com/content/author/author_id/55472426800",
            "ce:indexed-name": "Patel R."
        },
        {
            "ce:given-name": "Zoe June",
            "preferred-name": {
                "ce:given-name": "Zoe June",
                "ce:initials": "Z.J.",
                "ce:surname": "Assaf",
                "ce:indexed-name": "Assaf Z.J."
            },
            "@seq": "22",
            "ce:initials": "Z.J.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60026209",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026209"
            },
            "ce:degrees": "PhD",
            "ce:surname": "Assaf",
            "@auid": "57220095134",
            "author-url": "https://api.elsevier.com/content/author/author_id/57220095134",
            "ce:indexed-name": "Assaf Z.J."
        },
        {
            "ce:given-name": "David S.",
            "preferred-name": {
                "ce:given-name": "David S.",
                "ce:initials": "D.S.",
                "ce:surname": "Shames",
                "ce:indexed-name": "Shames D.S."
            },
            "@seq": "23",
            "ce:initials": "D.S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60026209",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026209"
            },
            "ce:degrees": "PhD",
            "ce:surname": "Shames",
            "@auid": "34573130000",
            "author-url": "https://api.elsevier.com/content/author/author_id/34573130000",
            "ce:indexed-name": "Shames D.S."
        },
        {
            "ce:given-name": "Michael S.",
            "preferred-name": {
                "ce:given-name": "Michael S.",
                "ce:initials": "M.S.",
                "ce:surname": "Mathisen",
                "ce:indexed-name": "Mathisen M.S."
            },
            "@seq": "24",
            "ce:initials": "M.S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60026209",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026209"
            },
            "ce:degrees": "PharmD",
            "ce:surname": "Mathisen",
            "@auid": "37091097200",
            "author-url": "https://api.elsevier.com/content/author/author_id/37091097200",
            "ce:indexed-name": "Mathisen M.S."
        },
        {
            "ce:given-name": "Shirish M.",
            "preferred-name": {
                "ce:given-name": "Shirish M.",
                "ce:initials": "S.M.",
                "ce:surname": "Gadgeel",
                "ce:indexed-name": "Gadgeel S.M."
            },
            "@seq": "25",
            "ce:initials": "S.M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60030704",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030704"
            },
            "ce:degrees": "MD",
            "ce:surname": "Gadgeel",
            "@auid": "6603479165",
            "author-url": "https://api.elsevier.com/content/author/author_id/6603479165",
            "ce:indexed-name": "Gadgeel S.M."
        }
    ]}
}}